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Abstract: Human liver microsomes (HLMs) contain the major drug metabolizing 
cytochrome P450 (CYP) enzyme, and their redox partner protein, CYP-NADPH reductase 
(CPR). Due to the broad range of biocatalytic reactions catalyzed by CYP enzymes, 
chemists have focused on the structure-function, biosensing, and catalytic applications of 
this unique class of enzymes. For drug development, HLMs are being used as the in vitro 
system to study drug metabolism, inhibition, isoform and metabolite profiling, biosensing 
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electrocatalytic pathways of human and bacterial (bactosomes) membrane-bound liver 
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CHAPTER I 
 
 
INTRODUCATION 
 
The objective of this dissertation is to understand the electrocatalytic properties of bacterial expressed 
cytochrome P450 (CYP) enzymes and human liver microsomes on new carbon electrode designs and 
nanostructures. Additionally, the use of electrochemistry as a tool to study meat color attributes based 
on myoglobin from different species under various pH conditions is demonstrated.    
          Human cytochrome P450 (CYP) enzymes represent a major class of drug metabolizing 
monooxygenases present in several organs (e.g., liver, lungs, and esophagus). CYP enzymes have 
gained attention among the catalysis, biochemistry, biomedical, bioengineering, pharmaceutical, 
electrochemistry, and toxicology communities due to their unique and broad substrate specificities and 
their ability to catalyze many stereoselective biochemically and technologically valuable reactions (e.g., 
carbon hydroxylation, epoxidation, heteroatom oxygenation, and dealkylation).1-7  
          For drug development, human liver microsomes (HLM) are being used as in vitro systems to 
study drug metabolism, inhibition, and drug-drug interactions and to identify the specific isoforms of 
CYPs involved in these processes.8 In the in vitro biological assays, NADPH used as an electron source 
delivered to reduce a CYP heme center mediated by reductase (CPR) via its flavin adenine dinucleotide 
(FAD) and flavin mononucleotide (FMN) cofactors.9 Replacing NADPH with an electrode as an 
electron source to study the direct electron transfer and catalytic properties of genetically engineered 
microsomes, rat liver microsomes, and HLM assembled as films with polyions, microsomes coated on 
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different thiolated hydrophobic gold electrodes, and layer-bylayer films of purified human CYPs and 
microsomal CPR have been performed successfully.10-13  
         Chapter II presents the detailed mechanistic study of the electrocatalytic pathway of 
membranebound CPR-CYP, only CYP and only CPR. Voltage-driven membrane-bound CYP-
catalyzed drug metabolite formation and quantification are demonstrated. Chapter III explores the 
electrocatalytic properties and reusability features of drug metabolizing human liver microsomes 
(HLM) adsorbed onto multiwalled carbon nanotubes (MWNT) coated on edge plane pyrolytic graphite 
electrodes (EPGs).  
           Chapter IV details the reduction and oxygenation kinetics of myoglobin at three different pH 
conditions (physiological state (pH 7.4), stressed animal muscle (pH 6.4), and post-mortem meat (pH 
5.6) were examined in this study). The electrochemically estimated oxygen affinity by reduced 
myoglobin at various pH conditions correlated with the color of meat.    
Chapter V investigates the species-specific effect (beef and pork) on metmyoglobin reduction potentials 
and oxygen affinity by cyclic voltammetry technique. 
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CHAPTER II 
 
 
MECHANISTIC INSIGHTS ON THE VOLTAGE-DRIVEN BIOCATALYSIS OF A 
CYTOCHROME P450 BACTOSOMAL FILM ON A SELF-ASSEMBLED 
MONOLAYRER 
2.1 Introduction  
Obtaining mechanistic insights on the electrocatalytic pathways of membrane-bound  
metalloenzymes is crucial for successfully designing viable enzyme bioelectrodes for catalysis and 
sensing applications. Among several catalytically important membrane-bound enzymes, human 
cytochrome P450 (CYP) enzymes represent a major class of drug metabolizing monooxygenases 
present in several organs (e.g., liver, lungs, and esophagus). CYP enzymes have gained attention 
among the catalysis, biochemistry, biomedical, bioengineering, pharmaceutical, electrochemistry, 
and toxicology communities due to their unique and broad substrate specificities and their ability 
to catalyze many stereoselective biochemically and technologically valuable reactions (e.g., carbon 
hydroxylation, epoxidation, heteroatom oxygenation, and dealkylation).1-12    
The CYP biocatalytic cycle involves substrate binding to the enzyme active site, reduction of the 
CYP-heme by CYP reductase (CPR) that uses NADPH as the electron source, a second electron 
reduction step (either by CPR or by cytochrome b5 in some CYP isoforms), and two protonation 
steps leading to the formation of CYP-ferryloxy radical cation (Scheme 1). This strong   
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oxidant can oxygenate the bound substrate and regenerate the resting ferric-heme state of the 
enzyme for subsequent catalytic turnover.13 In the case of isolated, soluble, and membrane-free 
CYPs, hydrogen peroxide (H2O2) can help to attain the active oxygenated form of CYPs (peroxide 
shunt pathway) for substrate monooxygenation.14,15   
In contrast to human CYPs, bacterial CYPcam (the abbreviation “cam” denotes camphor binding 
protein) utilizes an iron-sulfur protein, putidaredoxin, as the redox partner to deliver electrons from 
NADH. In the case of mitochondrial CYP enzymes (e.g., mammalian CYPscc, sterol 27-
hydroxylase or CYP 27A1), a non-heme iron-sulfur redox protein acts as the redox partner rather 
than NADPH CPR.16 Electrochemically, the need for a NADPH source can be eliminated by 
supplying electrons from an electrode under an applied negative potential either directly to the 
CYP-heme site or via CPR mediation.3,17-19 
Scheme 1. Proposed catalytic mechanism of human CYP enzymes.20 
 
    Representative electrochemical studies of films of various purified soluble CYP isoforms on 
electrodes include layer-by-layer films with polyions,14 CYPs mixed with surfactant films,21-24 
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various electrostatic film strategies,25 covalent attachment onto a gold (Au) self-assembled 
monolayer (SAM),26 and nanomaterial-modified electrodes.27-29 Isolation and purification of CYP 
enzymes involves tedious and time-consuming procedures that often yield very low amounts of 
CYP, and additionally they require extensive care to obtain active forms of purified enzymes. Due 
to these limitations, our focus is on electrocatalytic studies of membrane-bound forms of bacterial 
expressed CYP with its reductase.   
   Estabrook et al. demonstrated the feasibility of electrochemically driving CYP catalysis in 
solution containing the dissolved heme domain of rat CYP 4A1 fused with the flavin domain of rat 
NADPH CPR in the presence of cobalt complex electron transfer mediators.30,31 However, solution 
electrochemistry of proteins suffers from poor diffusion of large protein molecules to and from the 
electrode, electrode fouling by adsorbed inactive protein molecules, enzyme denaturation, 
associated charge transfer kinetic limitations, and difficulty in isolating product from the enzymatic 
solution for analysis. In contrast, protein film electrochemistry (PFE) is free of diffusion issues, as 
the protein is confined as a film at the electrode and efficient electron transport and electrocatalytic 
properties are possible via appropriate designs of electrodes for bioactive immobilization of  
enzymes.10,32 ,33   
   Successful PFE studies include genetically engineered membrane-bound forms of human CYP 
isoforms 1A2 and 3A4 with CPR (expressed in baculovirus-insect cells or E coli),17,18 
membranebound CYPs present in rat liver microsomes,34 human liver microsomes adsorbed on 
various carbon electrodes and carbon nanostructures,19,35,36 and layer-by-layer films of purified 
CYP 1A2 or 2E1 assembled with membrane-bound CPR on pyrolytic graphite electrodes.37 
Although CPR mediated CYP electrocatalysis was demonstrated, clear understanding of formal 
potentials and electrocatalytic pathways of membrane-bound films of CYP by themselves or in 
association with CPR is lacking.18 To address this knowledge gap, this study focused on CYP 2C9 
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(or 3A4)+CPR, CYP 2C9, CPR, and control bactosomes (no CYP or CPR present) as 
electrostatically adsorbed films on cysteamine SAMs of Au infused quartz crystals.   
           Higher metabolite formation in the presence of peroxide-scavenging catalase suggested the 
minimization of membrane oxidative stress and the insignificance of a peroxide shunt pathway in 
the CYP bactosomal films. This is in contrast to the catalytic property of isolated, soluble, and 
membrane-free CYPs that utilize H2O2 for catalysis.3,10,15 Moreover, formal potentials, oxygen 
reduction currents, and increased amounts of electrocatalytic diclofenac hydroxylation product 
confirmed the role of CPR in the CYP 2C9+CPR bactosomal film as the electron mediator from 
the electrode to the CYP 2C9-heme for catalysis. This quantitative bioelectrode construction 
method is simple, scalable (due to bacterial CYP expression systems for large scale CYP production 
with CPR), and useful for cost-effective, NADPH-free application of direct membranebound CYPs 
without the need for tedious isolation and purification of these enzymes to accomplish biocatalysis 
and for use in biosensing applications.   
2.2 Experimental  
2.2.1 Chemicals and materials  
          Catalase, cysteamine, and diclofenac were purchased from Sigma-Aldrich (St. Louis, MO, 
USA) and 4-hydroxydiclofenac was purchased from Cayman Chemicals (Ann Arbor, Michigan, 
USA). All other chemicals and reagents were analytical grade. For quartz crystal microbalance 
(QCM) measurements (Gamry Instruments, Warminster, PA, USA), Au infused quartz crystals (Au 
geometric area 0.2 cm2, International Crystal Mfg., Oklahoma City, USA) operating at a 
fundamental oscillation frequency of 10 MHz were used.   
CYP 2C9 expressed bactosomes with a residual CPR, CPR expressed bactosomes, CYP 2C9+CPR 
bactosomes, CYP 3A4+CPR bactosomes, and control bactosomes with no CYP or CPR were 
purchased from Cypex Ltd. (Dundee, Scotland, UK; US Distributor: Xenotech LLC, Kansas, 
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USA). Enzyme activities and protein concentrations in the bactosomes are provided in Table S1. 
As a representative case, we validated the supplier’s specifications of CYP 2C9 content and activity 
using CO difference spectra and by the standard NADPH CYP assay (Supporting Information, 
Figure S1, and associated validation results).37 Our results agreed with the supplier’s specifications.   
2.2.2 Instrumentation  
          QCM frequency changes and impedance spectroscopy measurements were made using an 
electrochemical quartz crystal microbalance (eQCM, Gamry Instruments) that interfaces a QCM 
with a potentiostat (Model: Interface 1000).38-41 Electrochemical and electrocatalytic properties of 
bactosomal films were examined with a CH instrument (Model: CHI 6017, Austin, TX, USA). As 
the representative characterization, CYP 3A4+CPR bactosomes adsorbed onto the SAM of 
cysteamine on the Au surface, only the cysteamine modified surface, and only the bare Au surface 
were characterized by scanning electron microscopy (SEM, Model: FEI Quanta 600FE). Zeta 
potential measurements were made using a ZetaPALS potential analyzer (Brookhaven Instruments 
Corporation, Holtsville, NY, USA). High-performance liquid chromatography (HPLC, premier 
C18 column, length 10 cm, Dionex, Model: UltiMate 3000, ThermoFisher Scientific) was used to 
identify the products of electrolysis of diclofenac catalyzed by the bactosomal films. A mobile 
phase composition of 30% acetonitrile:70% water was delivered at a flow rate of 0.3 mL min–1. 
Diclofenac and 4-hydroxydiclofenac peaks were identified based on chromatograms of standards 
run under similar conditions in the HPLC. Liquid chromatography-mass spectrometry (LC-MS) 
was performed using a 75-micron nano-LC column packed with 40 cm of C-18 beads (3 micron in 
diameter, MagicAQ beads from Bruker). A gradient elution was used proceeding from 100% 
mobile phase A (0.1% formic acid in water) to 80% mobile phase B (0.15% formic acid in 
acetonitrile). The column was eluted into the nanospray ion source of an LTQ-Orbitrap XL MS, 
and the mass spectra were collected in the FT mode using a nominal resolution of 60,000.  
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2.2.3 Electrochemical measurements   
          Electrochemical measurements were made in a standard three-electrode electrochemical cell 
consisting of an adsorbed bactosomal film on a cysteamine SAM on a Au infused quartz crystal as 
the working electrode, Ag/AgCl as the reference electrode, and a Pt wire as the counter electrode. 
Before performing cyclic voltammetry (CV) experiments for measuring redox potentials of the 
bactosomal films, 10 mL of phosphate buffer (pH 7.0) was argon purged for 30 min, and a constant 
argon atmosphere was maintained during measurements.   
2.2.4 Electrostatic adsorption of CYP 2C9 or 3A4 bactosomes onto Au SAM surface  
          A cysteamine solution (10 mM in ethanol) at a flow rate of 15 μL min–1 was allowed to pass 
over the surface of Au infused quartz crystals for 30 min. The crystals were washed with buffer 
until a constant oscillation frequency was obtained. The surface amine end groups of the cysteamine 
SAM were used to adsorb negatively charged phospholipid membranes19,34,42 of  bactosomes (CYP 
2C9, CPR, CYP 2C9+CPR, and CYP 3A4+CPR). As a representative case, zeta potential 
measurement of the CYP 2C9+CPR bactosomes in pH 7.0 indicated a negative surface charge with 
a value of −16.1 ± 1.8 mV (N = 3 replicates).   
The vendor-supplied bactosomal solutions were 10-times diluted in phosphate buffer (pH 7.0), 
which was found to be an optimal dilution to use in the QCM flow channel system. The electrostatic 
binding was conducted at a flow rate of 15 μL min–1 for 30 min at room temperature.  
For electrochemical studies, dilution of the bactosomes for adsorption onto the SAM Au quartz 
crystals is not required, so we used the bactosomes as supplied by the vendors. As controls, 
cysteamine SAM modified Au fused quartz crystals and those with adsorbed control bactosomes 
(with no CYP or CPR) were analyzed to estimate the non-enzymatic redox properties and to 
differentiate those from the electrocatalytic characteristics of the CYP and CYP+CPR bactosomal 
films.   
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2.2.5 Electrocatalytic oxygen reduction  
         Dioxygen is needed for CYP catalyzed reactions to form the reactive ferryloxy radical cation 
of CYP [+•(CYP-FeIV=O)] (Scheme 1). This oxoform helps oxygenate a CYP-specific substrate 
(e.g., diclofenac in our case). For dioxygen to bind to CYP, the reduction of CYP-FeIII-heme to 
CYPFeII-heme is necessary. This can be achieved electrochemically or by using chemical reducing 
agents.14 Under an applied negative potential in the absence of CYP substrate, the oxoform of CYP 
is reduced on electrodes to form H2O2, resulting in reduction currents with the regeneration of the 
resting ferric CYP-heme.3,14 In the present study, the oxygen reduction catalyzed by the designed 
CYP and CPR bactosomal films was studied in stirred buffer solutions to achieve O2 mass transport 
by convection.43 Control bactosomes, cysteamine SAM on Au, and bare Au infused quartz crystals 
were also tested for oxygen reduction properties to understand the contribution of CYP 
electrocatalytic activity in bactosomes.  
2.2.6 Electrocatalytic diclofenac hydroxylation by the bactosomal films   
         Enzyme catalytic activity to convert drug compounds into metabolites is the main goal of 
constructing any CYP immobilized films on electrodes. To examine the catalytic activity of   the 
bactosomal films (i.e., CYP 2C9, CPR, 2C9+CPR, and 3A4+CPR bactosomes), voltage-driven 
conversion of diclofenac to 4-hydroxydiclofenac in the presence of oxygen was examined at an 
applied potential of –0.6 V vs. Ag/AgCl reference (1 M KCl, CH Instruments) in 2 mL of phosphate 
buffer (pH 7.0) containing 100 µM of diclofenac in the presence of catalase (80 µL of 1 mg/mL 
catalase in pH 7.0 buffer; catalase specific activity 2000–5000 U/mg solid) or with no added 
catalase. The formation of 4-hydroxydiclofenac product was identified by HPLC, and its m/z was 
confirmed by a MS as described above under Section 2.3.  
2.2.7 Estimation of H2O2 formed with and without addition of catalase to electrolytic solutions  
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         Quantitation of H2O2 formed in the 100 µM diclofenac reaction mixture after 45 min of 
electrolysis using Au/cysteamine or Au/cysteamine/CYP bactosomal electrodes was carried out 
using an established fluorescence-based horseradish peroxidase/hydroquinone assay.44,45 In order 
to understand the role of H2O2 in the CYP catalyzed diclofenac hydroxylation in bactosomes, 
electrolysis was also conducted with addition of catalase to scavenge formed peroxide.   
2.3. Results and Discussion  
2.3.1 Bactosomal film preparation and characterization  
         Figure 1A shows a schematic of the electrostatically adsorbed assembly of CPR containing 
CYP bactosomes on a SAM of cysteamine on a Au infused quartz crystal. The formation of the 
cysteamine monolayer and subsequent adsorption of CYP 2C9+CPR or 3A4+CPR bactosomes was 
confirmed from the decrease in oscillation frequency measured using QCM (Figure 1B-C: please 
note that negative frequency value is plotted on the y-axis for better understanding of the net 
frequency change after each wash step). Using the Sauerbrey equation,38 the amount of 
selfassembled cysteamine layer was estimated to be 61 ± 7  ng, and that of the subsequent 
electrostatically adsorbed negatively charged CYP+CPR bactosomes was estimated to be 1.60 ± 
0.05 (2C9+CPR) and 1.46 ± 0.06 µg (3A4+CPR) (N = 3 replicates).   
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Figure 1. (A) Schematic of electrostatically adsorbed CYP+CPR bactosomal films on a cysteamine 
SAM on Au infused quartz crystals. (B) Real-time QCM curves showing the decrease in frequency 
upon the formation of the cysteamine SAM and the subsequent electrostatic adsorption of CYP 
3A4+CPR bactosomes. Sample injection points: (a) 10 mM cysteamine and (b) CYP 3A4+CPR 
bactosomes are labeled. Similarly in (C), (a) is for 10 mM cysteamine and (b) is for CYP 2C9+CPR 
bactosomes. Once the curve reached saturating response, the crystal surface was washed in 
phosphate buffer (pH 7.0) to remove bulk and unbound molecules in solution. The final baseline 
after each wash step indicates the net frequency decrease (due to added mass) for each surface 
modification. 
SEM images of a Au infused quartz crystal surface with a cysteamine SAM before and after the 
adsorption of CYP 3A4+CPR bactosomes confirmed the formation of the expected electrostatic 
assembly by displaying changes in surface morphologies for each step of modification (Figure S2 
a–c). Faradaic impedance spectroscopy measured in a Fe(CN)63–/4– mixture (each at 1 mM 
concentration in the mixture) as a redox probe showed an increase in Rct of 70 Ohms for the 
adsorption of CYP 3A4+CPR bactosomes on the cysteamine SAM modified Au infused quartz 
crystal (Figure S3-A). In agreement with this finding, non-faradaic impedance measurements made  
in the phosphate buffer (pH 7.0) in the absence of the redox probe showed an increase in impedance 
of ~80 Ohms for the adsorption of the CYP 3A4+CPR bactosomal film (Figure S3-B). 
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2.3.2 Direct electrochemistry of CYP bactosomal films   
          Cyclic voltammetry was used to study the direct electron transfer properties of CYP 2C9, 
CPR, CYP 2C9+CPR, and CYP 3A4+CPR bactosomal films assembled on the cysteamine SAM 
of Au infused quartz crystals. Figure 2 shows the background subtracted CVs of these films.   
 
Figure 2. Background subtracted cyclic voltammograms in argon purged phosphate buffer, pH 7.0, 
25 °C, scan rate 0.3 V s–1 of (a) CYP 2C9, (b) CPR, and (c) CYP 2C9+CPR bactosomal films 
electrostatically adsorbed on the cysteamine SAM modified Au infused quartz crystals.   
          The calculated formal potentials [Eo′ = (Ep, reduction + Ep, oxidation)/2; where Ep, 
reduction = reduction peak potential, Ep, oxidation = oxidation peak potential], electroactive 
surface charge (Q, area under the forward peak), and the peak width at half maximum (PWHM) of 
the enzyme films are detailed in Table 1. CYP 2C9 bactosomes showed a formal potential that was 
140 mV more positive than the CPR containing bactosomes. The similarity in the formal potentials 
between the CYP, 2C9+CPR and CPR bactosomes confirms that the CPR is the electron receiver 
from the SAM modified Au electrode in the CYP 2C9+CPR film. The 3A4+CPR bactosomal film 
exhibited a reduction potential similar to that of the CPR film (Figure S4), but the reverse peak was 
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less prominent, probably due to lower levels of expressed CPR (by 2.5-times) compared to that of 
the 2C9+CPR film (Table S1, product information). Only the cysteamine SAM on the Au infused 
quartz crystals showed no anaerobic redox peak at this potential region. The CPR redox peaks were 
attributed to the FAD/FMN cofactors with the flow of electrons known in biocatalysis from  
NADPH → CPR(FAD) → CPR(FMN) → CYP-heme to monooxygenate a CYP-bound substrate  
to product in the presence of molecular oxygen.9 The bactosomal CYP and CPR formal potentials 
are better resolved in the cysteamine SAM surface than that reported for naphthalene thiolate 
modified Au electrodes (−380 mV for CYP 3A4-microsomes and −410 mV for CPR-microsomes 
vs. Ag/AgCl).18 
CYP 2C9+CPR showed slightly higher electroactive protein amounts than the CYP 2C9 film 
(Table 1). CPR bactosomes showed a slightly lower electroactive protein amount. CYP 3A4+CPR, 
which had half the CYP concentration and a 2.5-times lower CPR concentration, showed half the 
electroactive charge with respect to the CYP 2C9+CPR film. The number of electrons involved in 
the direct electron transfer by the bactosomal films was estimated based on the PWHM values in 
anaerobic CVs (Figure 2). For an ideal thin film of an adsorbed species on an electrode, the PWHM 
for a one electron transfer process is 90.6 mV at 25 °C.43 The measured PWHM values shown in 
Table 1 suggest the non-ideal film voltammetry of the bactosomal films.   
    The PWHM of the CYP 2C9 bactosomal film is close to the one electron transfer process that 
would be expected for the CYP-heme cofactor. The PWHM of the CPR bactosomal film is close 
to the two electron limit and this suggests the electron receiving FAD cofactor of CPR 
communicating with the electrode.17,46 ,47 For the CYP (2C9 or 3A4)+CPR bactosomal films, the 
PWHM values are lower than that of the one electron CYP 2C9 film and correspond to either the 
CPR FAD cofactor alone and/or an intermediate mixed electron transfer process that could involve 
association of CYP with the CPR as a complex in the membrane.16 Nevertheless, the agreement 
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between the formal potentials of the CPR and CYP+CPR films strongly supports that CPR is the 
major electron receiver protein from the electrode (Table 1).  
Table 1. Electrochemical properties of the films in phosphate buffer pH 7.0.   
Bactosomal film 
type on 
Au/cysteamine 
surface  
Eᴼ´ (mV) vs. Ag/AgCl  Electroactive 
charge (nC)  
 PWHM  
(mV)  
CYP 3A4+CPR  −440 ± 40  107 ± 12   67 ± 5  
CYP 2C9+CPR  −450 ± 40  245 ± 23   62 ± 4  
CYP 2C9  −310 ± 20  221 ± 19   75 ± 3  
CPR  −450 ± 38  181 ± 13   56 ± 4  
Control bactosomes 
 (no CYP or CPR)  
No peak  No peak   No peak  
 Au/cysteamine   No peak   No peak   No peak  
 
2.3.3 Electrocatalytic oxygen reduction by CYP in bactosomal films   
         To examine the electrocatalytic oxygen reduction properties of CYP present in the designed 
bactosomal films, CV measurements were conducted in saturated oxygen buffer. Figure 3A(a–c) 
shows the oxygen reduction CVs of CYP 2C9, CPR, and CYP 2C9+CPR bactosomal films, 
respectively. Figure 3B(a–d) shows the oxygen reduction CVs of bare Au, Au/cysteamine, 
Au/cysteamine/control bactosomes (no CYP and no CPR), and the Au/cysteamine/CYP 3A4+CPR 
bactosomal film, respectively. The CYP 2C9+CPR bactosomal film provided the highest O2 
reduction current density of all films tested.   
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Figure 3. Catalytic oxygen reduction voltammograms of (A) (a) CYP 2C9, (b) CPR, and (c) CYP 
2C9+CPR bactosomal films. (B) (a) Bare Au, (b) Au/cysteamine, (c) Au/cysteamine/control 
bactosomes (no CYP or CPR present), and (d) Au/cysteamine/CYP 3A4+CPR bactosomal film in 
a stirred solution of phosphate buffer, pH 7.0, 25 ᴼC, under saturated oxygen conditions.  
                Table 2 lists the onset of O2 reduction potentials and O2 reduction currents measured from 
the catalytic CVs in Figure 3. The onset of O2 reduction catalyzed by the CYP 2C9 bactosomal film 
is ~ 100 mV more positive than that of the CYP 2C9+CPR or CYP 3A4+CPR films (Table 2), 
which is in accordance with the formal potentials in argon for CYP-heme and CPR molecules 
(Figure 2). This result confirms the direct CYP 2C9 mediated electrocatalysis in the case of CYP 
2C9 bactosomes. In the CYP 2C9 (or 3A4)+CPR films, the CPR mediates the transfer of electrons  
to CYP-heme from the electrode to initiate O2 reduction. Furthermore, during catalysis, the 
CPRCYP complex formation in the CYP 2C9+CPR bactosomes likely facilitates intermolecular 
electron transfer from CPR to CYP-heme in a manner similar to that of the natural biocatalytic 
pathway.16 The smaller O2 reduction current catalyzed by the CYP 3A4+CPR film can be attributed 
to the lower amounts of CPR and CYP in this bactosomes compared to the 2C9+CPR system (Table 
2 and Table S1). 
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Table 2. Onset of O2 reduction potential and current densities of the bactosomal films. 
Bactosomal film type on 
Au/cysteamine surface 
Onset potential of 
O2 reduction (mV) 
Current density 
(mA cm–2) at −0.5 V vs. 
Ag/AgCl 
CYP 3A4+CPR −235 ± 15 0.95 ± 0.09 
CYP 2C9+CPR −220 ± 11 1.30 ± 0.10 
CYP 2C9 −120 ± 9.4 0.90 ± 0.10 
Control bactosomes 
(no CYP or CPR) 
−248 ± 23 0.40 ± 0.01 
CPR −224 ± 8.5 0.70 ± 0.08 
Au/cysteamine −260 ± 1.3 0.74 ± 0.03 
 
              The non-enzymatic O2 reduction current generated by the cysteamine SAM film alone 
could be attributed to the secondary interactions of oxygen molecules with positively charged 
surface amine end groups. The resulting enrichment or localization of oxygen close to the Au 
surface, allows better interfacial charge transport and the oxygen reduction occurs. Similar oxygen 
reduction was exhibited by the CPR film with no CYP, likely arising from the electrocatalytic 
property of non-enzymatic cysteamine monolayer surface. However, the O2 reduction wave shapes 
of the cysteamine and the CPR bactosomal films differ, probably due to differences in the interfacial 
double layer structures. It has been reported that small molecules such as cysteamine chemisorbed 
on the Au surface can exhibit electrocatalytic oxygen reduction, but the exact reason has not been 
determined.48 Au and control bactosomes immobilized on the Au/cysteamine surface exhibited the 
smallest currents from non-enzymatic electrochemical O2 reduction. The observed formal 
potentials and the onset of O2 reduction currents indicate that (i) CYP enzyme is electrocatalytically 
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active in the designed bactosomal films and (ii) CPR mediates transfer of electrons to the CYP-
heme in CYP (2C9 or 3A4)+CPR bactosomal films to enhance oxygen reduction.   
2.3.4 Voltage-driven hydroxylation of diclofenac by bactosomal films   
         Voltage-driven conversion of diclofenac to 4-hydroxydiclofenac catalyzed by the designed 
bactosomal films (Figure 4A) was conducted at an applied potential of –0.6 V vs. Ag/AgCl for 45 
min in the presence of oxygen. This negative potential (~ 150 mV more negative than the formal 
potential of CPR) was used to provide sufficient reducing equivalents to the CYP-heme enzyme 
either directly (in the case of only CYP bactosomes) or via the CPR (for CYP+CPR films).   
Following electrolysis, the reaction mixture was analyzed for the hydroxylation product by HPLC. 
Diclofenac and 4-hydroxydiclofenac were eluted at retention times of 9 and 7.5 min, respectively 
(Figure 4A), which was confirmed by running diclofenac and 4-hydroxydiclofeanc standards and 
mass spectral identification of the expected m/z values for these compounds (Figure 4B). Two 
peaks with M+H values of 296 and 312 Da corresponding to the diclofenac and hydroxylated 
diclofenac molecules, respectively, were confirmed.   
                  The control bactosomal film that did not contain CYP and CPR formed no 
hydroxylation product, and only one peak with the retention time of 9 min corresponding to the 
diclofenac starting compound was observed (Fig. 4A-a). Table 3 provides the turnover rates for the 
various CYP bactosomal films examined in this study. Based on the volume and the known 
concentration of CYP in bactosomes used for adsorption, we calculated the added amount of CYP 
in pmoles and used this value to determine the turnover rates.  We used the added amount of CYP 
rather than the surface immobilized electroactive amount because in the case of CYP+CPR films, 
the electron transfer is to the CPR or its complex with CYP and not to CYP.  Thus, the calculation 
of electroactive CYP alone from CVs is not possible. Although this could be calculated for the CYP 
2C9 bactosomal film (i.e., no CPR control, Table 1), we used the added CYP amount present in the 
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bactosomal solutions to maintain consistency, which allowed relative comparison of turnover rates 
among films. 
 
Figure 4. (A) HPLC chromatograms of reaction mixtures (100 µM diclofenac in buffer) after 45 
min of applied voltage (–0.6 V vs. Ag/AgCl) to the Au/cysteamine monolayer on QCM crystals 
adsorbed with a film of (a) control bactosomes (no CYP or CPR present), (b) CPR, (c) CYP  
3A4+CPR, (d) CYP 2C9, (e) CYP 2C9+CPR bactosomes in the absence of catalase, and (f) CYP 
2C9+ CPR bactosomes in the presence of added catalase in phosphate buffer pH 7.0, saturated 
oxygen, 25 oC. (B) Mass spectrometry confirmation of diclofenac reactant (M+H 296 Da) and 4-
hydroxydiclofenac product (M+H 312 Da) from the CYP catalyzed electrolytic reaction mixture. 
                 Catalase was used to provide mechanistic insights about the voltage-driven biocatalysis 
of the bactosomal films on the SAM. The CYP 2C9+CPR bactosomal film showed a 6.5-fold 
(with catalase) and a 5.6-fold (without catalase) higher turnover rates than the respective CYP 
2C9 bactosomal films (Table 3). The greater turnover rate for the CYP 2C9 (or 3A4)+CPR film 
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confirmed the role of CPR in electron transfer to CYP 2C9 from the electrode surface to facilitate 
CYP 2C9 catalyzed diclofenac hydroxylation in the presence of oxygen. However, the small level 
of product from the CPR film suggests a non-specific electrocatalytic hydroxylation of diclofenac 
by this film (Fig. 4A-b). 
Table 3. Comparison of voltage-driven metabolite formation by different bactosomal electrodes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bactosomal bioelectrode Voltage-driven CYP 
turnover rate (pmol 
roduct pmol–1 CYP 
min–1 cm–2) 
CYP 2C9+CPR 
(no catalase) 
195±5 
CYP 2C9+CPR 
(catalase) 
410±22 
CYP 2C9 
(no catalase) 
35±4 
CYP 2C9 
(catalase) 
63±8 
CYP 3A4+CPR 
(no catalase) 
169±7 
Only CPR 
(no catalase) 
n/a 
Control bactosomes 
(no CYP, no CPR) 
n/a 
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2.3.5 Major CPR mediated CYP electrocatalysis in membrane-bound CYPs  
          In purified membrane-free soluble CYP based biocatalysis, H2O2 has been shown to 
be useful in forming the ferryloxy radical cation of CYP via the peroxide shunt pathway 
and facilitating substrate monooxygenation.15 Electrochemically, H2O2 can be generated 
by dioxygen reduction under an applied negative potential catalyzed by CYP films on 
electrodes for subsequent use in substrate oxygenation.49 If this was the case, then the 
peroxide shunt pathway of CYPs could play a role in bactosomes, as shown before for the 
purified CYP enzyme bioelectrodes.49,50 The amount of H2O2 formed in the electrolytic 
reaction mixture from the Au/cysteamine/control bactosomes (containing no CYP or CPR) 
and Au/cysteamine/CYP 3A4+CPR bactosomal electrodes (representative film) was 
estimated (by the horseradish peroxidase/hydroquinone assay) to be 63.5 ± 7.7 and 75 ± 12 
nmol, respectively. These H2O2 levels are not very different from each other, which 
indicates that the H2O2 formed is not utilized for electrocatalysis by the CYP+CPR 
bactosomal film and that the role of CPR in mediating electrons to reduce CYP-heme as in 
the natural CYP catalytic pathway is occurring (Scheme 2).   
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Scheme 2. CPR mediated CYP electrocatalytic pathway identified in the designed bactosomal film 
and the insignificance of peroxide shunt pathway in the case of membrane-bound CYP 
electrocatalysis.  
 
 
When we added an optimally identified concentration of catalase (80 µL of 1 mg/mL catalase of 
specific activity 2000–5000 U/mg) to the electrolysis solution containing CYP 2C9+CPR or CYP 
2C9 film on a cysteamine SAM on Au quartz crystals, the added catalase was sufficient to scavenge 
all H2O2 formed (confirmed by the horseradish peroxidase/hydroquinone assay). This electrolytic 
solution was then analyzed for the absence of 4-hydroxydiclofenac product formation. In contrast 
to our presumption, the electrolysis reaction mixture still showed two peaks with retention times at 
9 and 7.5 min for diclofenac and 4-hydroxydiclofenac, respectively, as observed for electrolysis 
with no added catalase (Figure 4A-d and e). In fact, addition of the catalase yielded a greater amount 
of hydroxylation product than when it was absent (Table 3). This observation suggests that catalase 
may eliminate the detrimental effect of reactive oxygen species on membranes (e.g., lipid 
peroxidation) from the electrochemically generated H2O2. As a result, the intact membrane 
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structure would be retained in the bactosomal film with bound CPR and CYP to offer better 
intermolecular electron transport from CPR to CYP and catalytic activity of CYP 2C9.   
                  More surprisingly, the CYP 2C9 bactosomal film also formed product in the presence 
of added catalase. This observation suggests that for membrane-bound CYP electrocatalysis of 
substrate oxygenation, peroxide has no significant role. It also suggests i) complete 
electrochemically reduced CYP 2C9 catalysis, with a possible trace of peroxide locally utilized 
inside the membrane and not measurable by the peroxide assay and/or ii) residual CPR mediated 
CYP catalysis is possible (Table S1 for product details). Nonetheless, the combination of CYP 2C9 
with CPR yielded significantly greater product than the CYP alone (Table 3).  Film stability 
assessment by the amperometric i-t curve (applied potential −0.6 V vs Ag/AgCl) under continuous 
catalytic oxygen reduction for the Au/cysteamine/P450 3A4 bactosomal electrode (representative 
case) displayed a half-life of 4 h (Figure S5). This stability is appreciable and sufficient to conduct 
the electrocatalysis despite the fact that film loss and reductive desorption of thiol on Au electrodes 
(at –0.6 V vs. Ag/AgCl) are possible.51  
2.4. Conclusions  
          This report provides new insights about the electrocatalytic pathways of CYP and CPR in a 
membrane environment at the molecular level for the first time. By systematically comparing CYP, 
CPR, and the combination of these two expressed in bactosomes, we were able to unambiguously 
discover the following properties: (i) in a bactosomal film, the CYP formal potential is −310 mV 
vs Ag/AgCl and is 140 mV more positive than that of CPR; (ii) the presence of CPR is significant  
for CYP electrocatalysis; (iii) H2O2 plays an insignificant role in the electrocatalysis of membrane- 
bound forms of CYP enzymes for monooxygenation of substrates; (iv) CPR mediated 
electrocatalysis operates in the CYP+CPR containing bactosomes; and (v) addition of catalase has 
24 
 
a favorable effect on enhancing the electrocatalytic product yield of CYP alone as well as 
CYP+CPR bactosomes. The insignificance of the H2O2 pathway in the membrane-bound form of  
CYP electrocatalysis contrasts with the catalysis by purified soluble forms of CYP enzymes.10,50   
2.5 SUPPORTING INFORMATION 
   Table S1. Bactosomal product specifications provided by Cypex Ltd. 
Product Protein 
concen-tration 
(mg mL-1) 
CYP 
concen-tration 
(nmol mL-1) 
Specific 
CYP 
concen-
tration 
(pmol mg 
protein-1) 
CYP 
Activity/Vmax 
(pmol product 
pmol-1 CYP 
min-1) 
CPR Activity 
(nmol min-1 
mg-1 protein) 
CPR 
concen-
tration 
(pmol mg 
protein-1) 
CYP 
3A4+CPR 
bactosomes 
10 1 100 69 574  190 
CYP 
2C9+CPR  
bactosomes 
12.6 2.4 190 98 1405  470 
Only 
CYP 2C9  
bactosomes 
13 2.8 215 n/a 1.1  0.4 
Only CPR  
bactosomes 
12.8 n/a n/a n/a 2281 
nmol min-1 
mL-1 
9.7 
nmol mL-1 
Control 
bactosomes 
10 n/a n/a n/a n/a n/a 
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2.5.1 Determination of total CYP 2C9 amount in bactosomes  
Method  
         The CYP 2C9 content in 2C9+CPR bactosomes was calculated using the carbon monoxide 
spectral assay optimized by Cypex Ltd (Dundee, Scotland, UK; Distributor: Xenotech LLC, 
Kansas, USA) with slight modifications.1 Briefly, a few grains of fresh sodium dithionite were 
added to a ten times diluted CYP 2C9+CPR bactosomes sample (3.00 mL) and split equally into 
two cuvettes labeled as sample and reference. Then the two cuvettes were placed in a Cary 100 
Bio UV-Visible dual beam spectrophotometer and the baseline and absorbance were recorded 
from 400-500 nm. Then the sample cuvette was removed from the spectrophotometer and the 
solution was bubbled with 5% CO at a rate of one bubble/second for 60 seconds. The sample 
cuvette was replaced and the overlay absorbance was recorded again from 400-500 nm. Multiple 
overlay scans were taken until the maximum CYP 2C9 absorbance was observed at 450 nm. The 
CYP 2C9 amount was calculated from the absorbance at 450 nm relative to 490 nm using the 
extinction coefficient of 0.091 µM-1 cm-1. 
Results and Calculation  
   
Figure S1. Difference absorption spectra of reduced CYP 2C9 bactosomes bound to carbon 
monoxide (solid line). Dotted line represents the base line. 
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Abs at 450 nm  = 0.025853  
Abs at 490 nm  = 0.004569  
Dilution factor = 10  
Ɛ CYP = 0.091 µM-1 cm-1  
Amount of total CYP = (OD450 - OD490)/(0.091) x Dilution  
               = 2.34 nmol/ml  
  
Estimated CYP amount was comparable with the value given in the Cypex product sheet, which 
was 2.4 nmol/mL.  
 2.5.2 Determination of CYP activity of CYP 2C9+CPR bactosomes  
Method  
          CYP activity in bactosomes was determined by the standard NADPH assay optimized by 
Cypex Ltd (Dundee, Scotland, UK; Distributor: Xenotech LLC, Kansas, USA). The following 
reagents were mixed in a 25 mL conical flask and placed in a 37° C water bath.  
 
200 mM potassium phosphate buffer, pH 7.4  1000 µL  
100 mM Magnesium chloride  250 µL  
2 mM diclofenac  6.25 µL  
Thawed bactosomes  6.25 µL  
Water  2737.50 µL  
200 mM potassium phosphate buffer, pH 7.4  1000 µL  
100 mM Magnesium chloride  250 µL  
2 mM diclofenac  6.25 µL  
Thawed bactosomes  6.25 µL  
Water  2737.50 µL  
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 The reaction was initiated by adding 1000 µL of pre-equilibrated (at 37° C) NADPH 
regenerating system (5 mM NADP, 25 mM glucose-6-phosphate and 5 mM glucose-6-phosphate 
dehydrogenase; Xenotech LLC, Kansas, USA) to the mixture. After 10 minutes, 200 µL of the 
reaction mixture was withdrawn and placed in a 1.5-mL micro centrifuge tube containing 200 µL 
of methanol (on ice) to stop the reaction. Then the tube was centrifuged at 13,000 rpm for 10 
minutes and the supernatant was analyzed by HPLC.  
2.5.3 Results   
         The CYP 2C9 activity was determined to be 69 pmol 4-hydroxydiclofenac per pmol CYP 
per min for a 2.5 µM substrate concentration. This value at this diclofenac concentration was in 
close agreement with the CYP activity data given in the Cypex product sheet.  
 
  
Figure S2. Representative SEM images of (a) bare Au electrode, (b) cysteamine adsorbed Au 
electrode, and (c) after CYP 3A4+CPR bactosome adsorption onto the cysteamine SAM.  
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Figure S3.  (A) (a) Au/cysteamine SAM and (b) after the adsorption of CYP 3A4+CPR bactosomes 
showing the increase in charge transfer resistance to the redox probe, Fe(CN)6 3–/4– (each at 1 
mM), in phosphate buffer (pH 7.0) at 0 V vs. Ag/AgCl, and (B) the corresponding increase in non-
faradaic impedance in redox probe-free phosphate buffer (pH 7.0) at 100 Hz and 0 V vs. Ag/AgCl.  
  
Figure S4. Cyclic voltammograms of (a) CYP 3A4+CPR bactosomes adsorbed electrostatically 
onto the SAM of cysteamine on a Au electrode and (b) SAM of cysteamine on a Au electrode. Scan 
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rate 0.3 V s-1, anaerobic phosphate buffer (pH 7.0) at 25 °C (* denotes the peak positions, which 
are less prominent in the reverse scan due to likely lower levels of CPR than the CYP 2C9+CPR 
film shown in Fig. 2. So no background subtraction was attempted for this 3A4+CPR film).    
 
Figure S5. Amperometric i-t curve assessing the catalytic oxygen reduction stability of 
Au/cysteamine/CYP 3A4+CPR bactosomal electrode at an applied potential of −0.6 V vs Ag/AgCl 
in oxygen saturated phosphate buffer at pH 7.0 and 25 °C. 
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CHAPTER III 
  
  
ELECTROCATALYSIS BY SUBCELLULAR LIVER FRACTIONS BOUND TO 
CARBON NANOSTRUCTURES FOR STEREOSELECTIVE GREEN DRUG 
METABOLITE SYNTHESIS 
  
3.1 Introduction  
Human liver microsomes (HLM) are subcellular fractions containing the major drug metabolizing 
cytochrome P450 (CYP) enzymes and their redox partner protein CYP-NADPH reductase (CPR).1 
Due to the broad range of biocatalytic reactions catalyzed by CYP enzymes (57 isoforms known in 
the liver) with inherent stereoselectivity, chemists have focused on the structure-function, 
biosensing, and catalytic applications of this unique class of enzymes.2-7 For new drug 
development, HLM are being used as in vitro systems to study drug metabolism, drug inhibition, 
and drug-drug interactions, and to identify the specific isoforms of CYPs involved in these 
processes.8 These in vitro assays use NADPH as the electron source. The electrons derived from 
NADPH are mediated by CPR via its flavin adenine dinucleotide (FAD) and flavin mononucleotide 
(FMN) cofactors to reduce CYP enzymes in their heme iron-FeIII state to heme iron-FeII, which 
facilitates dioxygen binding. Following the second electron reduction from CPR, the strong oxidant 
formed (i.e., the ferryloxy-CYP cation radical) can oxygenate bound drugs.1 Herein we describe 
the first liver microsomal electrocatalysis achieved on carbon nanostructure electrodes to convert 
a drug into its metabolite at enhanced yields.  
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                     The efficacy and pharmacokinetic properties of a drug depend on the biological 
activity of the metabolites formed in the liver and other organs mainly via CYP-catalyzed drug 
metabolism.9 Formation of reactive metabolites from a drug can cause hepatotoxicity by damaging 
DNA and other cellular protein-protein interactions. Hence, it is imperative to study the 
physicochemical and toxicity properties of new drugs for which sufficient drug metabolites are 
required.31,32 This report is significant and novel, as it demonstrates that the biocatalytic reactions 
of liver microsomes immobilized on high surface area nanostructure electrodes will allow the 
design of viable bioreactors for drug metabolite synthesis requiring only a small amount of 
microsomes.   
              Distinguished prior contributions by Arnold and co-workers include bioengineering of 
CYP enzymes to favorably tune the catalytic specificity and activity towards converting a desired 
substrate into products.12 Rusling et al. pioneered the CYP direct electrochemistry and 
electrocatalysis in films of polyions and surfactants. They additionally reported layer-by-layer films 
of genetically engineered specific CYP with CPR or rat liver microsomes or HLM assembled with 
polyions for direct electrochemistry and chemical toxicity evaluations.13 Gilardi et al. engineered 
CYP-fused CPR proteins to enhance catalytic activity by controlling the lifetime of the active 
ferryloxy oxidant form of CYP.14 Mie et al. designed thiolated gold electrodes with hydrophobic 
units to immobilize supersomes and demonstrated electrocatalytic properties.15   
              Recently, our laboratory examined the influences of various carbon electrode materials in 
the direct electron transfer and electrocatalytic properties of immobilized HLM.16 However, 
achieving highly enhanced electrocatalytic metabolite production from simple adsorption of 
complex HLM directly onto ‘3D’ carbon nanostructures with sufficient electrocatalytic stability 
and reusability features has not been reported previously. This novel, in vivo mimic biocatalytic 
system has the potential to realize the development of practically useful green bioreactors for 
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stereoselective metabolite production to assess physicochemical, toxicological, and biochemical 
properties of new drugs in development.  
               Specifically, we have discovered that HLM can be adsorbed onto multiwalled carbon 
nanotubes (MWNT) coated on edge plane pyrolytic graphite electrodes (EPGs) in bioactive form 
to offer enhanced production of drug metabolites by direct electrocatalysis. This finding simplifies 
the design of drug metabolizing CYP enzyme bioreactors because it eliminates the need for tedious, 
expensive, and time-consuming purification of CYP enzymes, and additionally allows 
identification of a specific liver CYP isoform involved in the metabolism of new drugs. Uniquely, 
we show that the designed HLM bioreactor on EPG/MWNT is reusable for metabolite generation 
with good stability and does not require expensive cofactors and electron transfer mediators. 
3.2 Experimental  
3.2.1 Chemicals and Materials   
             Edge plane pyrolytic graphite disk electrodes (geometric area 0.2 cm2) were prepared from 
pyrolytic graphite blocks (1 in. x 1 in. x 0.5 in., Momentive Performance Ltd., Strongsville, OH) 
in our machine shop. Multiwalled carbon nanotubes (MWNT, purity 99.1 %) were a gift from 
SouthWest Nano-Technologies Inc. (SWeNT, Norman, OK). Testosterone, L-α- 
phosphatidylcholine (denoted as PL), and standard 6β-hydroxytestosterone were purchased from 
Sigma-Aldrich. Human liver microsomes (HLM, total protein: 20 mg mL-1,   total amount of CYP 
enzymes: 0.58 nmol mg-1 protein, NADPH-cytochrome c reductase activity: 171 nmol mg-1 protein 
min-1, cytochrome b5: 0.439 nmol mg-1 protein, cytochrome P450-NADPH reductase (CPR) 
concentration: 0.057 nmol mg-1 protein) were purchased from XenoTetch (Lenexa, KS, USA). 
Microsomes containing only human CPR (expressed in Escherichia coli) was purchased from  
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Cypex Ltd. (Dundee, Scotland, UK) [CPR concentration: 9.7 nmol mL-1, total protein 
concentration: 12.8 mg mL-1]. All other chemicals were high-purity analytical grade. 
Electrochemical measurements were carried out in phosphate buffer containing 0.15 M NaCl (pH  
7.0) at 25 ᴼC.  
3.2.2 Instrumentation  
              A 3-electrode electrochemical cell consisting of an Ag/AgCl reference electrode (1M KCl, 
CH Instruments Inc.), a Pt wire counter electrode, and HLM adsorbed MWNT-coated PGE working 
electrodes were used. Electrochemical experiments were performed by using CH Instruments 
(Model: CHI 1040, Texas, USA). Cyclic voltammograms (CVs) were performed under argon 
purged anaerobic buffer to study direct electron transfer properties. For catalytic oxygen reduction 
studies, CVs were conducted by rotating disc voltammetry at a rotation rate of 300 rpm (EcoChemie 
Autolab rotator equipped with motor controller unit, Metrohm Inc., USA).17 The surface 
morphology of EPG, EPG/MWNT, and HLM adsorbed EPG/MWNT electrodes were imaged by 
scanning electron microscopy (Model: JEOL JXM 6400).   
3.2.3 Construction of MWNT modified HLM bioelectrode  
             Prior to use, EPG electrodes were polished on SiC paper (P320 grit), sonicated for 30 s, 
rinsed in deionized water and dried under nitrogen (N2). About 10 µL of MWNT (1 mg mL-1 
dispersion in DMF, obtained by ultrasonication at room temperature for 4 h) was dry-coated on 
polished EPG electrodes by leaving overnight at room temperature. The MWNT coated EPG 
electrodes (EPG/MWNT) were then washed with deionized water and dried under N2. 20 µL of 
HLM was adsorbed on EPG/MWNT electrodes for 30 min at 4 °C (denoted as EPG/MWNT/HLM). 
The electrodes were rinsed in deionized water and stored overnight at 4 °C before conducting 
electrochemical and electrocatalytic measurements.  
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3.2.4 Electrocatalytic hydroxylation of testosterone.   
           The electrocatalytic conversion of testosterone to 6β-hydroxytestoserone was identified by 
liquid chromatography. In brief, four HLM adsorbed EPG/MWNT electrodes were placed in a 10 
mL beaker containing 250 µM testosterone in 2 mL of phosphate buffer (pH 7.0). The electrolysis 
was carried out at an applied potential of -0.6 V vs Ag/AgCl for 1 h under saturated oxygen 
conditions using a multipotentiostat (CH Instruments, CHI 1040). The reaction mixture obtained 
from electrolysis was analyzed using high performance liquid chromatography (HPLC, premier 
C18 column, length 10 cm, Shimadzu). The mobile phase (30% acetonitrile, 70% water) was 
delivered at a flow rate 0.3 mL min-1. Testosterone and 6β-hydroxytestosterone were identified 
based on chromatograms of standards (Sigma) run under similar conditions.   
3.2.5 Hydrogen peroxide (H2O2) assay.    
              Hydrogen peroxide strips (EMD Millipore MQuant peroxide test strips, Billerica, MA, 
USA) were used to identify the H2O2 formation after the bulk electrolysis of testosterone 
hydroxylation by EPG/MWNT/HLM electrodes. The H2O2 formation arises from the 
electrocatalytic oxygen reduction by microsomal heme proteins. The electrolysis was carried out 
as described above. The H2O2 detecting strip was placed in 1 mL of 50 % diluted reaction mixture 
in buffer and the resulting color of the strip was compared with the H2O2 concentration scale 
provided by the manufacturer to identify the peroxide concentration formed in the electrolysis.   
3.3 Results and discussion    
           The surface morphologies of EPGs, EPG/MWNT electrodes, and HLM-coated 
EPG/MWNT electrodes were characterized by scanning electron microscopy (SEM, Figure 1). The 
characteristic surface defects of EPGs were covered by the MWNT, and subsequent physical 
adsorption of HLM led to the formation of a newly coated layer around the MWNT. This finding 
confirmed the immobilization of HLM on the EPG/MWNT surface (Figures 1 A-C).   
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Figure 1. Representative SEM images of A. polished bar EPG electrode, B. coated MWNT on the 
EPG electrode, and C. HLM adsorbed onto the MWNT-modified EPG electrode.  
            The cyclic voltammograms of the HLM adsorbed onto EPG/MWNT electrodes displayed a 
redox pair at a formal potential of –0.46 V vs. Ag/AgCl (Figure 2), which is in agreement with the 
formal potential of microsomal CPR film alone adsorbed on similar electrodes (Figure S1) and with 
results of other studies.13,18 No redox peaks at this potential region were observed for controle 
(Figure S2a,b). Thus, the cyclic voltammetry results confirmed the existence of direct electronic 
communication between HLM and MWNT-modified electrodes. Electrodes of EPG adsorbed with 
a phospholipid (PL) layer or EPG/MWNT in the absence of HLM (Figure S2a,b). Thus, the cyclic 
voltammetry results confirmed the existence of direct electronic communication between HLM and 
MWNT-modified electrodes.  
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Figure 2. Cyclic voltammograms of (a) unsubtracted and (b) background subtracted 
EPG/MWNT/HLM electrodes in argon atmosphere, phosphate buffer (pH 7.0) at 25 oC, scan rate 
0.3 V s-1. 
                   Figure S3 shows the cyclic voltammogram of a HLM film directly adsorbed onto a 
EPG in the absence of MWNT. The electroactive charge was calculated to be 340 ± 30 nC for 
microsomal proteins on EPG/MWNT/HLM electrodes, which was comparable to that observed for 
EPG/HLM films in the absence of coated MWNT (400 ± 45 nC). In contrast, the electrocatalytic 
oxygen reduction currents catalyzed by the microsomal heme proteins on EGP/MWNT/HLM 
electrodes was about two times greater than that of the EPG/HLM film (Figure 3a,b). Control 
EPG/PL and EPG/MWNT electrodes in the absence of adsorbed HLM showed small reduction 
currents arising from the electrocatalytic property of the edge planes of pyrolytic graphite and those 
present in MWNT (Figure 3c,d).19 
                        The electroactive coverage infers that compared to the enhancement factor in 
catalytic currents for the EPG/MWNT/HLM over the EPG/HLM electrodes, the direct electron 
transfer (ET) currents are not proportionately increased in EPG/MWNT/HLM. This could be due 
to the larger capacitive currents of MWNT-modified electrodes compared to bare EPGs (Figure 
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S2), which could act as a barrier to observing unhindered non-turnover currents from the 
EPG/MWNT/HLM electrodes in argon atmosphere. This finding also emphasizes the high enzyme 
turnover rates in the presence of a substrate, and it shows that the associated large catalytic currents 
can overcome the charging current effect of MWNT-coated electrodes (Figure 3a). In addition to 
the enhanced oxygen reduction currents, the EPG/MWNT/HLM electrodes exhibited greater 
electrode-driven bioactivity in converting testosterone to 6β- hydroxytestosterone, which is a 
characteristic of CYP enzymes present in HLM as explained below.   
 
Figure 3. Rotating disc catalytic oxygen reduction voltammograms of (a) EPG/MWNT/HLM, (b)  
EPG/HLM, (c) EPG/MWNT, and (d) EPG/PL films in saturated oxygen, phosphate buffer (pH 7.0) 
at 25 °C, 300 rpm rotation rate, scan rate 0.3 V s-1. 
      The biocatalytic properties of microsomal enzymes on EPG/MWNT/HLM and EPG/HLM 
electrodes were studied by bulk electrolysis at an applied potential of –0.6 V vs. Ag/AgCl in the 
presence of oxygen in phosphate buffer (pH 7.0) containing dissolved testosterone (250 µM). The 
reaction mixture was analyzed by high performance liquid chromatography. The identification of 
the reactant and product in the chromatograms was accomplished by running standard solutions of 
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testosterone and 6β-hydroxytestosterone under similar conditions (Figure S4). CYP 2C19, 2C9, 
and 3A4 present in HLM have been shown to hydroxylate testosterone.20  
             Figure 4 shows the chromatograms of 6β-hydroxytestosterone product formation from 
testosterone conversion electrocatalyzed by EPG/MWNT/HLM (chromatogram a) and EPG/HLM 
electrodes (chromatogram e). The absence of product formation by the control EPG/PL and 
EPG/MWNT electrodes (Figure S5) clearly confirms the role of CYP enzymes present in HLM in 
catalyzing testosterone conversion in the EPG/MWNT/HLM and EPG/HLM electrodes. The 
reusability of EPG/MWNT/HLM electrodes was examined by replenishing fresh testosterone 
solutions following each electrolysis and by repeating the reaction under an applied potential of –
0.6 V vs.  Ag/AgCl (chromatograms b-d). 
 
Figure 4. HPLC chromatograms of 250 µM testosterone in phosphate buffer (pH 7.0) after every 
1 h bulk electrolysis of (a-d) EPG/MWNT/HLM electrodes or (e) EPG/HLM electrodes at –0.6 V 
vs. Ag/AgCl under saturated oxygen conditon at 25 °C. For b-d, fresh testosterone solution was 
supplied following the removal of each prior electrolysis reaction mixture to examine the 
reusability of EPG/MWNT/HLM electrodes.   
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               Figure 5A shows the increase in currents with increasing testosterone concentration 
monitored  by chronoamperometry at an applied constant potential of –0.6 V vs. Ag/AgCl under 
atmospheric air condition at 25 °C for EPG/MWNT/HLM and EPG/HLM electrodes (a and b, 
respectively). Control electrodes of only EPG/MWNT and EPG/PL in the absence of HLM did not 
show any increase in currents as shown in Figure 5A (c and d) suggesting the role of HLM in 
testosterone catalytic currents. We found that the large background currents under saturated oxygen 
condition interfered with the detection of current signals from added testosterone electrolysis in 
chronoamperometry. Hence, the use of atmospheric air (~ 21 % oxygen) was identified to offer 
small, but constant baseline currents and allowed monitoring subsequent increases in currents with 
testosterone concentration (Figure 5A). Electrochemical Michaelis-Menten fitting of the 
testosterone catalytic currents offered apparent Michaelis-Menten affinity constants (KMapp) of 290 
± 33 µM for EPG/MWNT/HLM and 480 ± 51 µM EPG/HLM electrodes towards testerone 
substrate (Figure 5B a and b).13a The lower  KMapp of EPG/MWNT/HLM indicates the stronger 
affinity of HLM adsorbed to MWNT for testosterone. 
 
Figure 5.  (A) Amperometric evidence of testosterone electrocatalysis by (a) EPG/MWNT/HLM 
and (b) EPG/HLM films at –0.6 V vs. Ag/AgCl, 25 °C, pH 7.0 buffer, 150 rpm electrode rotation 
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rate, atmospheric air condition.  Amperometric curves for control electrodes (c) EPG/MWNT and 
(d) EPG/PL in the absence of HLM under similar conditions. (B) Electrochemical Michaelis- 
Menten kinetics of testosterone hydroxylation by (a) EPG/MWNT/HLM and (b) EPG/HLM films. 
                      Results suggest that the testosterone hydroxylation by microsomal CYP enzymes in 
HLM may involve electron mediation by reductases from the electrode to CYPs heme centers.13,15 
By obtaining the calibration plot of standard 6β-hydroxytestosterone (Figure S6), we were able to 
determine that 2.2 ± 0.3 and 0.45 ± 0.06 nmol of metabolite were formed by the EPG/MWNT/HLM 
and EPG/HLM electrodes, respectively, per unit EPG geometric area (in cm2). This suggests a 5-
fold enhancement in the amount of metabolite produced by HLM immobilized on MWNT-
modified electrodes. Figure 4(b) shows that 45–50 % of the initial product yield was obtained upon 
reuse of the EPG/MWNT/HLM electrodes. Subsequent reuses of the electrodes decreased the 
amount of metabolite formation to 20–25% [2nd reuse, Figure 4(c)] and 10% [3rd reuse, Figure 
4(d)]. Each reaction was carried out twice for duplicate measurements, and the reproducibility of 
product levels was good (standard deviation was within 15%).   
               Figure 6 presents the film stability of HLM coated on the catalytically superior 
EPG/MWNT electrode in the presence of oxygen examined by chronoamperometry at an applied 
potential of – 0.6 V vs. Ag/AgCl in phosphate buffer (pH 7.0). The half-life of the 
EPG/MWNT/HLM electrode was found to be 10 h.  Thus, the stability of the HLM film on 
EPG/MWNT electrodes did not appear to affect the catalytic yields significantly with the number 
of reuses. This is because within 4 h, i.e., the time sufficient to complete the biocatalysis with the 
reuse of electrodes for three times (Figure 4), only about 20% loss in catalytic current was noted 
(Figure 6).   
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Figure 6. Amperometric i-t curve assessing the catalytic oxygen reduction stability of 
EPG/MWNT/HLM electrodes at an applied potential of -0.6 V vs Ag/AgCl in oxygen saturated 
phosphate buffer, pH 7.0 at 25 oC. 
     Using peroxide assay strips (Millipore Inc., MA, USA), we found that ~ 3 µmol of H2O2 were 
formed in the electrolytic reaction after 1 h electrolysis of EPG/MWNT/HLM electrodes in the 
presence of oxygen and testosterone. On the other hand, no detectable H2O2 amount was formed in 
the absence of HLM on EPG/MWNT electrodes under similar electrolysis conditions, suggesting 
the catalytic role of microsomal heme proteins in forming colorimetrically measurable peroxide 
levels from oxygen reduction (Figure 3).13  We suggest the possible role of H2O2 towards 
microsomal lipid peroxidation that could cause a detrimental effect on the organization of 
membrane-bound microsomal enzyme films and associated electrocatalytic bioactivity.21,22 Thus, 
the observed decrease in product yield with number of reuses of the EPG/MWNT/HLM electrodes 
was likely due to the extensive lipid peroxidation by repeated H2O2 stress caused by the electrolysis 
process. Detailed investigation is required to understand this presumed possibility. 
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                  Designing stable electrocatalytic enzyme films is a huge challenge, and we expected 
that doing so using complex liver microsomes on nanostructure electrodes would be even more 
challenging. Despite this presumption, we observed reasonably good stability for HLM films on 
EPG/MWNT electrodes. This suggests the favorable secondary interactions of microsomal 
membranes with predominantly hydrophobic MWNT to retain the intact membrane-bound protein 
structures with drug metabolizing bioactivity as uniquely demonstrated in this report. The favorable 
interaction of phospholipid membranes of HLM with MWNT appears to be also reflected in the 
lower KMapp of EPG/MWNT/HLM for testosterone substrate. 
3.4 Conclusions   
                We have successfully developed a novel electrochemical liver microsomal bioreactor on 
carbon nanostructured electrodes for the first time. The results above suggest that the system offers 
direct bioelectronic communication between the microsomal proteins and ‘3D’ MWNT modified 
electrodes. Electrocatalytic conversion of testosterone into its metabolite in the presence of oxygen 
showed significant enhancement on EPG/MWNT/HLM in comparison with EPG/HLM. The 
stability of the constructed bioelectrode was sufficient for reusability. Furthermore, 
chronoamperometry studies showed the EPG/MWNT/HLM electrode displayed high enzyme 
activity and strong affinity towards substrate. Our approach provides a new direction in the design 
of practically viable enzyme bioreactors that do not require purified enzymes and that can be used 
for green chemical synthesis and biosensing applications. 
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3.5 SUPPORTING INFORMATION 
 
Figure S1. Cyclic voltammograms of (a) unsubtracted and (b) background subtracted  
EPG/MWNT/CPR electrode in argon atmosphere, phosphate buffer (pH 7.0) at 25 °C, scan rate 
0.3 V s-1. 
 
Figure S2. Cyclic voltammograms of (a) EPG/MWNT and (b) EPG/PL electrodes in the absence 
of HLM in argon atmosphere, phosphate buffer (pH 7.0) at 25 °C; scan rate 0.3 V s-1. 
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Figure S3. Cyclic voltammograms of (a) unsubtracted and (b) background subtracted EPG/HLM 
electrode in argon atmosphere, phosphate buffer pH 7.0 at 25 ᴼC, scan rate 0.3 V s-1. 
 
Figure S4. High performance liquid chromatograms of 250 µM testosterone and  
6β-hydroxytestosterone standards in phosphate buffer (pH 7.0) at 25 °C. 
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Figure S5. High performance liquid chromatograms of reaction mixtures after 1 h bulk electrolysis 
of (a) EPG/MWNT and (b) EPG/PL electrodes (no HLM present) in 250 µM testosterone, 
phosphate buffer pH 7.0 at -0.6 V vs Ag/AgCl under saturated oxygen conditions at 25 °C.   
 
 
Figure S6. Calibration plot showing the peak area versus concentration of standard 6β- 
hydroxytestosterone. 
 
 
 
50 
 
3.6 REFERENCES 
1. Ortiz de Montellano, P. R. 3rd Ed., Cytochrome P450, Kluwer/Plenum, New York, 2005.  
2. (a) Guengerich, F. P.; Munro, A. W. J. Biol. Chem. 2013, 288, 17065-17073; (b)  
             Guengerich, F. P. J. Biochem. Mol. Toxicol. 2007, 21,163-168  
3. Zanger, U. M.; Schwab, M. Pharmacol. Ther. 2013, 138, 103-41.  
 4. Li, A. P. Drug Discov. Today Technol. 2005, 2, 179-185.  
 5. (a) Krishnan, S.; Bajrami, B.; Hvastkovs, E. G.; Choudhary, D.; Schenkman, J. B.;       
              Rusling, J. F. Anal. Chem. 2008, 80, 5279-5285; (b) Wasalathanthri, D. P.; Li, D.; Song,                
              D.; Zheng, Z.; Choudhary, D.; Jansson, I.; Lu, X.; Schenkman, J. B.; Rusling, J. F.  
             Chem. Sci. 2015, 6, 2457-2468.  
6. Schneider, E.; Clark, D. S. Cytochrome P450 (CYP) enzymes and the development of  
             CYP biosensors, Biosens. Bioelec. 2013, 39, 1-13.  
7. O'Reilly, E.; Koehler, V.; Flitsch, S.; Turner, N. Chem. Commun. 2011, 47, 2490-2501.  
8. Wienkers, L. C.; Heath, T. G. Nat. Rev. Drug Discov. 2005, 4, 825-833.  
 9. Ma, Q.; Lu, A. Y. H.  Pharmacol. Rev. 2011, 63, 437-459.    
10. Park, B. K.; Boobis, A.; Clarke, S. et al. Nat. Rev. Drug Discov.  2011, 10, 292-306.  
11. Deavall, D. G.; Martin, E. A.; Horner, J. M.; Roberts, R. J. Toxicol. vol. 2012, Article ID  
             645460, 13 pages, 2012. doi:10.1155/2012/645460  
12. Jung, S. T.; Lauchli, R.; Arnold, F. H. Curr. Opin. Biotechnol. 2011, 22, 809-817.  
 13. (a) Krishnan, S.; Schenkman, J. B.; Rusling, J. F. J. Phys. Chem. B 2011, 115, 8371-           
              8380; (b) Krishnan, S.; Wasalathanthri, D.; Zhao, L.; Schenkman, J. B.; Rusling, J. F.  J.        
             Am. Chem. Soc. 2011, 133, 1459–1465; (c) Sultana, N.; Schenkman, J. B.;  Rusling, J. F.  
51 
 
            Electroanalysis 2007, 19, 2499-2506.  
14. Dodhia, V. R.; Sassone, C.; Fantuzzi, A.; Nardo, G. D.; Sadeghi, S. J.; Gilardi, G.  
             Electrochem. Commun. 2008, 10, 1744-1747.  
15. Mie, Y.; Suzuki, M.; Komatsu, Y. J. Am. Chem. Soc. 2009, 131, 6646-6647.  
16. Walgama, C.; Nerimetla, R.; Materer, N. F.; Schildkraut, D.; Elman, J. F.; Krishnan, S.   
            Anal. Chem. 2015, 87, 4712-4718. 
17. (a) Krishnan, S.; Abeykoon, A.; Schenkman, J. B.  Rusling, J. F. J. Am. Chem. Soc.          
              2009, 131, 16215-16224; (b) Krishnan, S.; Armstrong, F. A. Chem. Sci. 2012, 3, 1015-  
             1023.  
18. Shukla, A.; Gillam, E. M. J.; Bernhardt, P. V. Electrochem. Commun. 2006, 8, 1845- 
            1849.  
19. Banks, C. E.; Compton, R. G. Analyst 2006, 131, 15-21.  
20. Yamazaki, H.; Shimada, T. Arch. Biochem. Biophys. 1997, 346, 161-169.  
21. Ursini, F.; Maiorino, M.; Ferri, L.;Valente, M.; Gregolin, C. J. Inorg. Biochem. 1981, 15,  
            163-169. 
 22.      Iqbal, M.;Okazaki, Y.; and Okada, S. Teratog. Carcinog. Mutagen. 2003, 23, 151–160.   
 
 
 
 
 
 
 
52 
 
 
 
 
  CHAPTER IV 
CORRRELATING THE ELECTROCHEMICAL KINETICS OF MYOGLOBIN-FILMS 
TO pH DEPENDENT MEAT COLOR 
 
4.1 Introduction  
                The color of meat is the first deciding factor that influences the purchase decisions of 
consumers.1 Meat color is primarily determined by the oxidation state of myoglobin (Mb).2,3 For 
example, the red color of meat is influenced by the proportion of oxymyoglobin (Mb-FeII-O2) to 
metmyoglobin (Mb-FeIII) present. The greater the Mb-FeII-O2/Mb-FeIII ratio the brighter the red 
color. Mb has been a good electrochemical model heme-protein due to its easy commercial 
availability, relatively inexpensive nature, and peroxidase-like enzyme activity. Several 
electrochemical studies were reported on the direct electron transfer (ET) and catalytic peroxidase-
like reduction kinetics of Mb films constructed on electrodes.4 -7 In addition, the role of distal 
histidine (His-64) in the direct electron transfer properties and oxygenation of myoglobin were well 
documented.8 -14 Recently, the application of nanomaterials in enhancing the redox and catalytic 
properties of Mb and other heme enzymes were also examined.15 -19  Moreover, Mb-modified 
electrodes were designed to provide sensitive peroxide detection and other sensing and certain 
catalytic applications.7,20 -22 The redox potential of Mb in meat changes with pH. In an 
electrochemical sense, one can observe that the electron-transfer process in a heme-protein is 
coupled with proton transfers, from the more positive formal potential shifts with decreasing pH, 
as per the Nernst equation.10,13 Numerous research reports are available on the proton-coupled  
electron-transfer processes in myoglobin and its oxygen-reduction properties.4,10,13,54-56  
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However, to our knowledge, understanding the color of meat with respect to pH conditions, from 
the electrochemical kinetics of metmyoglobin reduction rate and oxymyoglobin formation-
constant, has not been reported before.  
 4.2 Experimental  
              Equine heart myoglobin (Mb), monosodium dihydrogen phosphate, disodium hydrogen 
phosphate, and sodium chloride were purchased from Sigma. High-purity graphite-disk (HPG, 
EDM Inc., MN, USA) electrodes were used for both cyclic voltammetry (CV) and rotating disk 
electrochemistry (RDE). For RDE experiments, an electrode rotation rate of 2000 rpm (Eco Chemie 
Autolab rotator with a motor controller, Metrohm Inc., USA) was employed. Electrochemical 
measurements were performed in a 3-electrode electrochemical cell (CH instruments, Model CHI 
6017, Texas, USA) employing a Ag/AgCl reference electrode (1 M KCl, CH Instruments), a Pt-
wire counter electrode, and HPG rotating disk working electrode coated with a Mb film. Before 
use, HPG-electrodes were polished on P320 SiC-grit paper, rinsed well in water, and dried under 
nitrogen.  
             The myoglobin films on electrodes were prepared by placing a solution of myoglobin (3 
mg mL-1 in the respective pH-buffer) for 10 min on freshly polished HPG-electrodes at 4 °C to 
allow physisorption involving electrostatic and other secondary interactions of Mb with the 
electrode surface.10 The free Mb solution was rinsed off in deionized water and the Mb-film coated 
electrodes were then used for electrochemical measurements.  CV was performed under nitrogen 
atmosphere at different pH conditions to obtain reduction and oxidation peak potentials with 
increasing scan rate, and to determine the rates of metmyoglobin, Mb-FeIII, reduction rate, and its 
reoxidation in the reverse scan. RDE was conducted at different concentrations of oxygen in 
nitrogen, added to the cell using 2 mass flow controllers (Aalborg Instruments & Controls Inc.,  
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NY, USA).26 To investigate the oxymyoglobin formation constant at pH 5.6, 6.4 and 7.4, 
electrochemical Michaelis-Menten kinetics were employed. Unless otherwise specified, mixed 
sodium phosphate buffer solutions were used (0.1 M containing 0.15 M NaCl, pH 5.6, pH 6.4, or 
pH 7.4) to make Mb solutions in each pH buffer, to prepare the respective films on polished HPG 
electrodes, and to do the electrochemical experiments in the respective Mb-free pH buffer.    
4.3 Results and discussion   
                 Immediately after harvesting an animal, the postmortem metabolism changes from 
aerobic to anaerobic. This shift in metabolism results in the accumulation of lactic acid as an end 
product, hence, the pH drops from 7.4 (physiological pH) to 5.6 (postmortem muscle pH).27 On the 
other hand, animals exposed to chronic stress such as that arising from transportation and 
temperature, before being slaughtered, leads to the production of certain levels of glycogen in the 
tissue. Therefore, the pH drop is relatively less (pH 6.4) as there exists limited glycogen availability 
to form lactic acid. There are several factors that can affect meat color. For example, postmortem 
muscle is biochemically active and enzymes such as cytochrome-b5 reductase and lactate 
dehydrogenase can influence the meat-color by providing reducing equivalents to heme-proteins 
including Mb, which is a main-pigment in meat-muscle.  
                 In addition, oxidation of lipids can generate various primary and secondary lipid-
oxidation products which can accelerate myoglobin-oxidation.28 Previous research has utilized 
spectrophotometric methods to characterize myoglobin oxidation and oxygenation. However, 
limited knowledge is currently available regarding the reduction kinetics of metMb at different pH.  
Using Mb-films immobilized on high-purity graphite (HPG) electrodes, we demonstrate here the 
usefulness of protein-film electrochemistry in the preliminary understanding and correlation to the 
pH dependent meat-color. 
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Figure 1. (A) Representative background subtracted cyclic voltammograms of Mb films adsorbed 
on HPG electrodes in anaerobic mixed phosphate buffers at (a) pH 7.4, (b) pH 6.4, and (c) pH 
5.6. Scan rate: 0.7 Vs-1, 25oC. (B) Trumpet plots showing the peak separation with increasing 
scan rate for Mb-films on HPG electrodes at pH conditions defined in (A). (C) Direct electron 
transfer rate constants determined by Laviron’s method for the Mb films at pH 7.4, 6.4 and 5.6. 
                 In the current study, equine myoglobin was selected as the myoglobin model because it 
shares 88.2 and 90.8 % homology with bovine and porcine myoglobins, respectively 
(www.expasy.org), and it is easily obtained through commercial sources. The bioactivity of the 
Mb-film was tested by choosing the oxidation of o-methoxyphenol as a model reaction.29,30 Four 
HPG electrodes coated with Mb-films were used to catalyze the reaction to obtain enough products 
for suitable measurement by absorbance. The Mb-films were found to be active in converting o-
methoxyphenol (25 nmol) into 3,3'-dimethoxy-4,4'-biphenylquinone (9 nmol) in the presence of 
hydrogen peroxide (0.5 mM). The product formation was confirmed by measuring the absorbance 
maximum at 482 nm.31   
            Fig. 1A shows the representative anaerobic cyclic voltammograms of Mb-films physisorbed 
on HPG-electrodes at the designed three pH conditions. The peak potentials shifted more positive 
with decreasing pH from 7.4 to 5.6, confirming the proton-coupled ET-process. The shifts in 
midpoint potential per pH-unit was 56 mV (Table 1), which is close to the ideal nernstian shift of 
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59 mV pH-1 for a one-electron proton coupled ET-process.32 The electroactive enzyme coverage 
was 0.02-0.03 nmol cm-2 in the pH range 5.6-7.4. Within this pH range, the reduction peak 
potentials shifted more negative with increasing scan rate, the peak-current versus scan rate was 
linear, the oxidation to reduction peak current ratios were close to unity, and the average peak-
width at halfheight was around 130 mV (Table 1). All these properties suggest non-ideal surface-
voltammetry of Mb-films at the tested pH values on HPG-electrodes.13,18,19   
           Fig. 1B displays the peak-separation between the oxidation and the reduction for Mb-films 
at different pH-values with the logarithm of scan rate (so called “trumpet plots”). The observed 
extent of peak-separation with pH was in the following order: pH 5.6 > pH 6.4 > pH 7.4. From the 
increase in peak-separation with scan rate, we obtained the direct ET-rate constants for 
metmyoglobin-reduction and reoxidation in the designed Mb films by Laviron’s method.33  
             The rates of metmyoglobin reduction were observed to be in the following order at three 
different pH values [technically it is the overall rate for a quasi-reversible redox process, however, 
for practical convenience, we are terming it as the metmyoglobin reduction due to its propensity to 
complex with O2 under normal exposure to air in a meat, where Mb-reduction is performed by 
redox partner proteins]: pH 7.4 > pH 6.4 > pH 5.6. The smaller peak-separation observed for 
Mbfilms at pH 7.4 correlated well with its greater metmyoglobin reduction rate at this compared 
with pH 6.4 and pH 5.6 conditions (Fig. 1C).    
              Figures 2A-C represent the steady-state oxymyoglobin reduction currents with increasing 
oxygen concentration for Mb-films adsorbed on HPG-electrodes at pH 7.4, 6.4, and 5.6, 
respectively. The corresponding plots of oxygen concentration with the electrochemical reduction 
of formed Mb-FeII-O2 yielding reduction currents at each pH condition are shown in Figures 2DF, 
respectively. The formation constants of Mb-FeII-O2 at different pH conditions can be related to 
the Michaelis-Menten KM values. Here, lower KM indciates higher O2 binding affinity of Mb at 
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a given pH. The extent of oxymyoglobin formation decides the intensity of the bright-red color of 
a meat. The pH-dependent increasing order of average KM values obtained from the 
MichaelisMenten fit18 of the data shown in Figures 2D-F was the following: pH 7.4 < pH 5.6 ≈ 
pH 6.4 (Table 1).    
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Figure 6.2. Steady-state oxymyoglobin reduction voltammograms of Mb films adsorbed on HPG 
electrodes with increasing oxygen concentration at (A) pH 7.4, (B) pH 6.4, and (C) pH 5.6.  The 
oxygen concentrations shown are a. 0,    b. 210,   c. 300, d. 396, and e. 600 µM. The corresponding 
oxymyoglobin reduction currents versus oxygen concentration following the Michaelis-Menten 
kinetics are shown for (D) pH 7.4, (E) pH 6.4, and (F) pH 5.6.  Experimental conditions: 25 oC, 
2000 rpm rotation rate, scan rate 0.1 V s-1. 
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Table 6.1. Electrochemical properties and oxymyoglobin affinity constants at pH 5.6, 6.4, and 
7.4. 
 
           Thus, at pH 7.4, the formation of oxymyoglobin seems to be highly enhanced due to the 
observed high affinity between O2 and reduced metmyolobin (low KM, Table 1). This is additionally 
supported by the contribution from faster metmyoglobin reduction rate at pH 7.4 as shown in Fig. 
1C. Whereas, the oxymyoglobin formation as well as the metmyoglobin reduction rates are 
relatively weaker at acidic pH 5.6 and pH 6.4 conditions (Fig. 1C and Table 1). This implies a large 
proportion of Mb-molecules present as metmyoglobin at acidic conditions, and hence the associated 
fading color of meat at pH 5.6 with time. While at physiological pH 7.4, both the metmyoglobin 
reduction rates and oxymyoglobin formation constant are significantly enhanced (Figure 1C and 
Table 1, KM values), and thus can favor the red color of meat at this pH. 
                  In agreement to prior studies, the highly possible enhanced H-bond network around 
distal His64 (pKa 6.0)9 in Mb with decrasing pH from 7.4 to 5.6 is suggested to increase the 
activation barrier for ET.10,13 This in turn can explain the observed decreasing order of ET-rates of 
metMb films from pH 7.4 to 5.6 (Fig. 1C), and the correlating trend of oxygenation affinity constant 
that requires the reduced-Mb-FeII state for O2 binding (Table 1). The observed direct 
pH E / V vs 
Ag / AgCl 
 
Γ / 
(nmol cm-2) 
Peak-width 
at half –height 
(mV) 
KM 
(µM) 
5.6 -0.27 
(± 0.01) 
0.03 
(± 0.01) 
131 
(± 10) 
742 
(± 90) 
6.4 
 
-0.31 
(± 0.01) 
0.03 
(± 0.01) 
127 
(± 5) 
780 
(± 82) 
7.4 -0.37 
( ± 0.01) 
0.02 
(±  0.005) 
130 
(± 9) 
551 
(± 35) 
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elecrochemical properties are also in good correlation with the biochemical and redox-titration 
studies that reported the faster decoloration of meat with lowering pH conditions.34-36 In addition, 
the metmyoglobin reducing activity in beef is often used as a tool to predict beef color. For example, 
a greater reducing activity results in brighter red meat color. Thus, our study is the first of its kind 
in providing insights on the color of meat with pH from the electrochemical investigation of 
metmyoglobin reduction and oxymyoglobin formation rates, by using an electrode as the electron 
donor that mimicked the in vivo function of reductases in delivering electrons to Mb.37   
     4.4 Conclusions  
                In summary, the results presented above demonstrate that direct electrochemistry of Mb-         
films can provide insights on the color of meat with pH conditions. We have tested three pH    
conditions, relevant to the physiological, stressed animal muscle, and post-mortem meat. The  
observed greater electrochemical metmyoglobin reduction rate and stronger oxymyoglobin  
formation constant at pH 7.4, correlated well with the bright-red color of fresh meat at this pH  
over acidic conditions. Thus, understanding the biochemical redox-processes of myoglobin by  
electrochemical methods is invaluable in designing novel tools to predict meat color and quality.  
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CHAPTER V 
 
SPECIES-SPECIFICITY IN MYOGLOBIN OXYGENATION AND REDUCTION 
POTENTIAL PROPERTIES 
  
5.1 Introduction   
The characteristic bright cherry-red color of beef is the primary determinant that influences 
consumers’ decision to purchase meat.1 Myoglobin is the protein primarily responsible for meat 
color, and it can exist in three different forms; namely deoxy-, oxy, or metmyoglobin. Myoglobin 
consists of a heme ring surrounded by globin. The iron present in the heme has six coordination 
sites, of which, four are occupied by protoporphyrin ring, the fifth by His93 residue, and the sixth 
site by ligands such as oxygen, water, or carbon monoxide. The ligand attached to the central heme 
and the valence state of iron determine meat color. In deoxymyoglobin, heme is in the ferrous state 
and no ligand is attached. Oxygen binding to ferrous heme results in the formation of 
oxymyoglobin. However, oxidation of oxy- and deoxymyoglobin leads to metmyoglobin 
formation.2 Hence, processes that can promote oxymyoglobin formation (oxygenation) and 
metmyoglobin reducing activity can influence meat color.  
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Meat has an inherent capacity to limit myoglobin oxidation by a process called metmyoglobin 
reducing activity. To date, research has been focused on the role of enzymes, mitochondria, and 
NADH levels in metmyoglobin reducing capacity.2 The ability of the heme to undergo reduction 
and/or oxygen binding ability and amino acid sequence also can affect meat color.  
The application of electrochemical methods will help to investigate the changes in the 
microenvironment of heme at the active site of myoglobin.3 Thus, characterizing the 
interrelationship between myoglobin reduction potential and oxygen binding properties will 
increase our knowledge related to meat color.  
              Previous research reported that myoglobin oxidation is species-specific and it depends on 
the primary amino acid sequence.4 More specifically, the number of histidine residues in the 
myoglobin of meat-producing livestock species can influence myoglobin redox stability.22 The 
amino acid composition can affect the three-dimensional structure, hence the ability of heme to an 
accept an electron or oxygen. Nevertheless, we are not aware of any report detailing the species-
specific effects on myoglobin reduction potential and oxygen binding capacity. Therefore, the 
objective of the current study was to compare the myoglobin oxygenation and reduction potential 
properties of bovine and porcine myoglobins using electrochemical methods in-vitro.  
5.2 Materials and methods   
5.2.1 Materials and chemicals  
              High-purity graphite (HPG) disc electrodes (geometric area 0.2 cm2) were purchased from  
McMaster-Carr (Atlanta, GA). Silicon carbide (SiC) paper, monosodium hydrogen phosphate 
(NaH2PO4.H2O), disodium hydrogen phosphate (Na2HPO4) and sodium chloride (NaCl) were 
purchased from Sigma-Aldrich (St. Louis, MO). All chemicals were of analytical grade or greater 
purity.   
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5.2.2 Myoglobin isolation  
           Ammonium sulfate precipitation and gel-filtration techniques were used to isolate 
myoglobin from porcine and bovine heart.6 Briefly, beef and porcine cardiac muscle devoid of fat 
and connective tissue was homogenized in buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0, 4 °C) 
and centrifuged at 5000 x g for 10 min. The supernatant was brought to 70% ammonium sulfate 
saturation, and the resulting solution was stirred for 1 h at 4 °C and then centrifuged at 18,000 x g 
for 20 min. The supernatant was then saturated with ammonium sulfate (100%) and centrifuged at 
20,000 x g for 1 h. The precipitate was re-suspended in homogenization buffer and dialyzed (3 
volumes) against 10 mM Tris-HCl, 1 mM EDTA, at pH 8.0 and 4 °C for 24 h. Myoglobin was 
separated from hemoglobin using a Sephacryl 200-HR gel filtration column (2.5 x 100 cm) using 
5 mM Tris-HCl, 1 mM EDTA, pH 8.0 as the mobile phase at 1 mL/min. The isolated myoglobin 
was a mixture of oxy-, deoxy-, and metmyoglobin. To limit the interference of oxidizing agents on 
metmyoglobin reduction, the myoglobin solution was transferred into a glass tube, and 
metmyoglobin was prepared by incubating myoglobin at 37 °C for 24 h. Samples were stored at 
−80 °C until used.   
5.2.3 Electrochemical studies  
5.2.3.1 Immobilization of beef and porcine Mb on high purity graphite electrodes  
           High purity graphite (HPG) electrodes were polished using a silicon carbide paper (P320 
grit) and sonicated for 30 sec. After being rinsed in deionized water, the electrodes were dried under 
nitrogen. Ten microliters of purified bovine or porcine metmyoglobin (0.15 mM) were adsorbed 
on freshly polished HPG electrodes and incubated for 10 min at 4 °C to allow physisorption 
involving electrostatic and other secondary interactions.24 The electrodes were then rinsed in 
deionized water to remove unbound myoglobin and the myoglobin coated HPG electrodes were 
used for electrochemical studies.  
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5.2.3.2 Myoglobin reduction potential and oxygenation measurements  
Myoglobin reduction potential and oxygenation properties were determined by the methodology 
described by.18 Cyclic voltammetry was used to determine the reduction potential and oxygenation 
properties of bovine and porcine myoglobins. Cyclic voltammetry (CV) studies were performed 
using a CH Instrument (CHI 1040, Bee Cave, TX) with HPG as the working electrode, platinum 
(Pt) wire as a counter electrode, and Ag/AgCl (1 M KCl) as the reference electrode. The cyclic 
voltammetry experiments were performed using 0.1 M of 10 mL mixed phosphate buffer (pH 5.6, 
6.4, and 7.4) under anaerobic conditions; and these pH conditions represented postmortem muscle, 
dark-cutting beef, and physiological, pHs, respectively. Different pH buffers were prepared by 
mixing mono- and disodium hydrogen phosphate. The cyclic voltammetry experiments were 
performed at room temperature.  
                For oxygenation studies, various concentrations of oxygen (0 – 1200 µM) and nitrogen 
were supplied to the electrochemical cell using two mass flow controllers (Aalborg Instruments & 
Controls Inc., NY; model GFC17) and the percentage oxygen was converted to molar concentration 
using Henry’s equation.10,15 Nitrogen and oxygen gas were of ultra-high purity (Matheson Tri-Gas, 
Basking Ridge, NJ). Zero percent oxygen level was achieved by purging with nitrogen gas. Unless 
otherwise specified, all electrochemical measurements were performed in an anaerobic mixed 
phosphate buffer (0.1 M containing 0.15 M NaCl, at pH 5.6, 6.4, or 7.4,) under a nitrogen 
atmosphere. To investigate the oxymyoglobin formation constants at pH 5.6, 6.4, and 7.4, 
electrochemical Michaelis-Menten kinetics were employed.7 The formation of an oxymyoglobin 
(FeII-O2) complex upon the reduction of metmyoglobin in the presence of oxygen gives rise to 
catalytic currents in proportion to oxygen concentration (due to the reduction of formed FeII-O2 on 
the electrode surface at the negative potential region). The greater the oxygen binding, the larger is 
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the resulting current. The relationship between oxymyoglobin reduction current and concentration 
of oxygen fits well in the Michaelis-Menten equation. The following formula was used to determine 
the myoglobin affinity for oxygen.  
      𝑛𝐹𝐴𝛤𝑘𝑐𝑎𝑡𝐶𝑠 
                                                                         𝐼𝑐𝑎𝑡 =    
        𝐶𝑠 + 𝐾𝑀   
             Where n is the number of electrons in the reaction (n=2), F is faraday’s constant, A is the 
electrode area (0.2 cm2), Γ is the electroactive amount (mol cm-2) of protein on an electrode, Cs is 
the concentration of oxygen, and KM is the oxymyoglobin formation constant or Michaelis-Menten 
constant. KM indicates the affinity of oxygen to bind with the reduced heme; a lower number 
indicates greater oxygen affinity. Icat is the catalytic property of the enzyme when it reacts with the 
substrate. It increases when the substrate (O2) binds to myoglobin in its reduced state. kcat is a 
catalytic constant also called the turnover number. The turnover number of an enzyme (myoglobin) 
is the number of substrate molecules (O2) that are converted to product per unit time when the 
enzyme (myoglobin) is fully saturated with substrate (O2).  
              A range of 0 to -0.6 V was applied to the myoglobin containing electrodes for reduction 
potential studies. The respective buffer was purged with nitrogen gas to attain zero oxygen 
concentration. Cyclic voltammetry was performed at different pH conditions to obtain reduction 
and oxidation peak potentials. The electrode was rotated (Eco Chemie Autolab rotator with a motor 
controller, Metrohm Inc., USA) at a rate of 2000 rpm to get steady state conditions. A lower number 
indicates myoglobin has greater reduction potential or a tendency to get reduced quickly.  
5.2.4 Myoglobin modeling  
The structure of the bovine (Bos taurus) myoglobin was predicted using the structure of porcine 
oxy-myoglobin form (protein data bank id: PDB 1 MNO), a homolog, for which the 3dimensional 
structure has been determined by X-ray diffraction method.12  
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This homology-based modeling was conducted using the Iterative Threading Assembly  
Refinement (I-TASSER) server.23,28,29 This homology-based modeling study with I-TASSER 
involves three steps: template identification from the PDB library, assembly of iterative structures, 
and structure-based function annotation. I-TASSER identifies the homologous structure models 
from the PDB4 using a Local Meta-Threading-Server algorithm.25 The secondary structure of the 
target protein was predicted based on sequence information from the Protein Secondary Structure 
PREDiction (PSSpred) algorithm.28 The lowest free energy conformations were determined by 
SPICKER (a clustering approach to identify near-native protein folds.34 Refinement of the low 
free energy conformations was done by using FG-MD.31,32 Prediction of the ligand-binding site of 
the target protein was made by the COACH algorithm.27  
 The distance between Nε of the His 64, His 93 and His 97 and the iron and oxygen molecule of 
the heme group in the crystal structure of porcine myoglobin (PDB: 1MNO) was calculated using 
PyMOL (version 1.8). The distance between Nε of the His 64, His 93 and His 97 and the iron 
molecule of the heme group in the predicted structure of bovine myoglobin was also determined 
using PyMOL.  
5.2.5 Statistical analysis  
 The experimental protocol was a completely randomized design (n = 6). The fixed effects include 
pH, species, and their interaction. Type-3 tests of fixed effects were performed using the MIXED 
Procedure of SAS (Version 9.1, SAS Institute Inc. Cary, NC). Least squares means for protected 
F-tests (P < 0.05) were separated by using the pdiff option (least significant differences) and were 
considered significant at P < 0.05.  
5.3 Results   
5.3.1 Effects of pH and species on oxygenation properties  
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For oxygenation studies, 0 – 1600 µM of oxygen was allowed to bind with myoglobin at pH 5.6, 
6.4, or 7.4. A pH species interaction resulted for oxygenation properties (P = 0.04; Table 1). Porcine 
myoglobin had a greater oxygen affinity than beef myoglobin at the same pH (P = 0.04; Figure 1 
and Table 1). The formation of oxymyoglobin results in a catalytic current.  Figure 1 represents 
oxymyoglobin formation with different levels of oxygen. The relationship between oxygen 
concentration and the resultant current followed the Michaelis-Menten kinetics data. The numbers 
in the Table 1 were derived from the Michaelis-Menten kinetics data using a K-graph software. 
Kinetic parameters (KM and kcat) were extracted from Michaelis-Menten figure data. A lower KM 
value indicates a greater affinity for oxygen binding to myoglobin at a given pH condition. The 
homology-based myoglobin modeling indicates that the porcine myoglobin has a shorter distance 
between distal histidine and heme than bovine (Table 2 and Figure 2).  
Table 1. Effects of pH and species on oxygenation property1 on porcine and bovine myoglobins 
Trait    Oxygen affinity (µM)1  SE  P-value  
a) pH effect  pH 5.6  852.4  29.4  0.0002  
  
pH 6.4  591.2    
  
  
pH 7.4  749.5    
  
          
b) Species effect  Beef  851.4  24.0  < 0.0001  
  
Pork  610.2  
    
          
c) pH x species effect  pH 5.6, beef   932.4d 41.2  0.0420  
  
pH 5.6, pork   772.4bc      
  
pH 6.4, beef   778.4c      
  
pH 6.4, pork   404.5a      
  pH 7.4, beef   844.0cd      
  pH 7.4, pork   655.0b      
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a-dLeast square means with different superscripts significantly differ (P < 0.05).            1Michaelis-
Menten constants (KM) indicate the oxygen affinity in micromolar. Lower KM value indicates a 
greater affinity for oxygen binding to Mb at a given pH condition. SE indicates the standard error. 
Table 2. Comparison of distance (in Angstrom) from proximal and distance histidine to heme 
iron in bovine and porcine myoglobins 
Distance measured  Bovine  Porcine  
His64 Nε- Fe  5.6  4.3  
His64 Nε - oxygen   **  2.6  
His93 Nε- Fe   2.2  2.2  
His97 Nε- Fe   5.5  5.4  
 
5.3.2 Effects of pH and species on reduction potential properties  
The effect of pH was significant for the myoglobin reduction potential (P < 0.0001; Table3). At pH 
5.6, the myoglobin reduction potential was -306.3 mV compared with -362.8 mV at pH 7.4 (P < 
0.0001). The reduction potential value provides information about the ability of heme within 
myoglobin to accept electrons. Myoglobin redox potentials shifted more negative with increasing 
pH from 5.6 to 7.4, indicating a proton-coupled electron transfer process. The reduction potential 
values demonstrated no differences between species (P = 0.51) and also for species x pH interaction 
(P = 0.91). 
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Table 3. Effects of pH and species on reduction potential1 properties on porcine and bovine 
myoglobins 
Trait    Reduction potential (mV)  SE  P-value  
a) pH effect  pH 5.6  -306.3a 2.3  < 0.0001  
  
pH 6.4  -319.2b    
  
  
pH 7.4  -362.8c    
  
b) Species effect  Beef  -328.6  1.8  0.5162  
  
Pork  -330.3  
    
c) pH x species effect  pH 5.6, beef   -305.2  4.6  0.9185  
  
pH 5.6, pork   -307.4      
  
pH 6.4, beef   -319.3      
  
pH 6.4, pork   -319.0      
  pH 7.4, beef   -361.4      
  pH 7.4, pork   -364.5      
 
a-cLeast square means with different superscripts significantly differ (P < 0.05). SE indicates the 
standard error. 
5. 4 Discussion   
               Meat is a complex system; various processes and organelles such as mitochondria, lipid 
oxidation, and microorganisms compete for oxygen. Hence, to study oxygen binding properties 
specifically to myoglobin in a meat system might be challenging. We utilized an electrochemical 
approach to understanding the biochemical basis of oxygen binding to myoglobin in vitro. Various 
research has employed cyclic voltammetry to study protein functionality and successfully 
extrapolated the effects under physiological conditions.7,20  
              The mechanistic basis for species-specific effects of oxygen binding on myoglobin is not 
clear. In the current study, porcine myoglobin had greater oxygen affinity conditions than bovine 
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myoglobin. Porcine and bovine myoglobin share 88% amino acid sequence homology 
(www.expasy.org; Table 4). Further, the differences in amino acid sequence between species could 
be partially responsible for changes in oxygen affinity. The amino acid sequence can affect the net 
charge of a protein and its affinity for oxygen. Marcinek et al. (2001) reported that oxygen binding 
depends on the amino acid sequence surrounding the heme pocket. In addition, the primary amino 
acid sequence can affect the tertiary structure, which in turn can influence interactions with ligands 
and also the volume of the heme cavity.22 In support, Bunn (1971) reported that porcine hemoglobin 
has greater oxygen affinity than bovine hemoglobin, due to differences in amino acid composition. 
Furthermore, variation in the primary structure was responsible for species-specific effects of 
secondary lipid oxidation products on myoglobin redox stability.22 For example, porcine myoglobin 
contains 9 histidine residues, while bovine myoglobin contains 13 such residues. The lower the 
number of nucleophilic histidins in porcine myoglobin than bovine is responsible for its greater 
redox stability against 4-hydroxy-2-nonenal. More specifically, 4-hydroxy-2-nonenal can 
preferentially bind with nucleophilic histidins that are available for reaction.  
                  In addition to differences in the number of histidine residues, differences in distances 
between the distal histidine and the heme can influence oxygen binding. The distal histidine plays 
a significant role in stabilizing the oxygen bound to heme. A shorter distance between the distal 
histidine and the heme in porcine myoglobin might have favored oxygen binding to the heme 
compared with bovine myoglobin.  
                 At pH 5.6, the net charge of bovine myoglobin and porcine myoglobin were, 12.4 and 
8.8, respectively (http://protcalc.sourceforge.net/). A greater positive charge could be less favorable 
for oxygen to bind with beef myoglobin. Although the exact mechanism is not clear, we speculate 
from medical research. More specifically, hemoglobin at a lower pH (greater positive charge) has 
a lower affinity for oxygen due to the Bohr effect (Benesch and Benesch, 1961).  
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               However, in myoglobin, a lower pH minimizes heme-apomyoglobin contact.13 This 
support the current research that the oxygen affinity was lower at pH 5.6 compared with 6.4 and 
7.4 within a species. Previous research using steaks reported greater oxygenation or bloom in pork 
than beef (Hass and Brazlter, 1965). Greater oxygen affinity to porcine myoglobin, in part, could 
be responsible for more bloom in pork than beef. Porcine myoglobin has been crystallized, but, 
bovine myoglobin has not been crystallized yet.3 Hence, it was not possible to compare the amino 
acid sequence surrounding the heme cavity. Interestingly, in the current study, the oxygen affinity 
was greater at pH 6.4 than pH 5.6 and 7.4 for both species. Distal histidine plays a major role in 
stabilizing ligands such as oxygen. The pKa of histidine is 6.1. Since the pKa is close to pH 6.4 
compared with pH 5.6 and 7.4, a lower charge difference might have favored oxygenation.    
 
Figure 1. The Michaelis - Menten kinetics1 observed for the reduction currents of beef and pork 
myoglobin versus O2 concentration in pH 5.6, 6.4, and 7.4 
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Figure 2. Three-dimensional representation of porcine and bovine myoglobins 
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Figure 3. Comparison of amino acid sequences of porcine and bovine myoglobin. Differences in 
amino acids are represented by a text box. The first row represents bovine myoglobin and the 
second row represents porcine myoglobin 
             In the present study, there was no significant effect of species on reduction potential. The 
results suggest that there were no differences between species at a particular pH to accept an 
electron. However, there was a significant effect of pH on the reduction potential. A pH of 7.4 
favored reduction more than a pH of 6.4 or 5.6. Previous research using equine myoglobin also 
reported a greater metmyoglobin reduction at pH 7.4.18 Greater metmyoglobin reducing activity at 
an elevated pH in meat, can in part, and can be attributed to the ability of heme to accept an electron 
more quickly than normal pH. Metmyoglobin reduction changes with conditions and also depends 
on the type of system used. For example, Elroy et al. (2015) reported that porcine and bovine 
myoglobin have different non-enzymatic metmyoglobin reduction capacity. The enzymatic 
reaction involves three-dimensional binding of co-factors and proteins, which aid in electron 
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transfer to ferric heme. However, application of a potential to a graphite electrode will move an 
electron directly to heme.  
5.5 Conclusions  
                A meat matrix is composed of various biomolecules; hence to study myoglobin 
functional properties can be challenging. The current study suggests that cyclic voltammetry is a 
useful tool to characterize myoglobin reduction potentials and oxygenation properties. Oxygen 
binding to myoglobin is species-specific. Further, homology-based modeling helps to explain the 
speciesspecific variation in myoglobin properties. The results indicate that cyclic voltammetry can 
be a valuable tool to understand meat biochemical properties such as the effects of pH on bloom, 
effects of temperature on myoglobin reduction potential, and the role of lipid oxidation products 
on myoglobin redox stability.  
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CHAPTER VI 
 
CONCLUSIONS 
  
In Chapter II, the electrocatalytic pathway of CPR-mediated electrocatalysis operative in the 
CYP+CPR containing bactosomes and the favorable effect of catalase in enhancing the 
electrocatalytic product yield of CYP+CPR bactosomes were determined. New mechanistic 
insights about the electrocatalytic function of CYP bactosomes with CPR were obtained. The 
simplicity and cost-effective nature of the designed bioelectrodes is useful for drug metabolism 
assays, biosensing, and biocatalytic applications.  
In Chapter III, designed liver microsomal bioreactors on carbon nanostructured electrodes offered 
direct electrochemical communication between the microsomal proteins and MWNT-modified 
electrodes, direct electrocatalysis, sufficient catalytic stability, and reusable features.   
            In Chapter IV, we observed direct electrochemical communication between the microsomal 
proteins combined with MNP modified EPG or) electrodes. Chronoamperometry studies showed 
that MNP/HLM electrodes displayed good enzyme activity, direct electrocatalysis and strong 
substrate affinity. MNP/HLM electrodes are promising for cost-effective development of 
microsomal drug metabolite bioreactors for new drugs in development.  
We have tested three pH conditions, relevant to the physiological, stress animal muscle and 
postmortem meat (Chapters V and VI). The observed greater electrochemical metmyoglobin 
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reduction and stronger oxymyoglobin formation constant at pH 7.4 correlated well with the bright-
red color of a fresh meat at this pH over acidic pH. Understanding the redox-processes of meat by 
electrochemical methods is valuable in designing novel tools to predict meat color and quality. 
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